var title_f34_44_35520="Ketotifen: Patient drug information";
var content_f34_44_35520=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ketotifen: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F13254415\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F13254416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/1/3092?source=see_link\">",
"       Ketotifen (ophthalmic): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16826 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-E13A3EE944-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35520=[""].join("\n");
var outline_f34_44_35520=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/1/3092?source=related_link\">",
"      Ketotifen (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_44_35521="Management of suspected meningitis in children";
var content_f34_44_35521=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 515px\">",
"   <div class=\"ttl\">",
"    Management algorithm for infants (&ge;1 month) and children with suspected bacterial meningitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 495px; height: 647px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     STAT: intervention should be performed emergently; CBC: complete blood count; PT: prothrombin time; PTT: partial thromboplastin time; BUN: blood urea nitrogen; CSF: cerebrospinal fluid.",
"     <br/>",
"     * Antimicrobial therapy should not be delayed if lumbar puncture cannot be performed or is unsuccessful.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Decisions regarding the administration of dexamethasone should be individualized depending on careful analysis of the risks and benefits as discussed in the text. (See \"Treatment and prognosis of acute bacterial meningitis in children\").",
"     <br/>",
"     &Delta; Empiric antibiotic therapy and dexamethasone (if warranted) should be administered immediately after cerebrospinal fluid is obtained; if dexamethasone is to be administered, it should be given before, or immediately after, the first dose of antimicrobial therapy.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from:",
"     <ol>",
"      <li>",
"       Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267",
"      </li>",
"      <li>",
"       Fleisher GR. Infectious disease emergencies. In: Textbook of Pediatric Emergency Medicine, 5th ed, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.792.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35521=[""].join("\n");
var outline_f34_44_35521=null;
var title_f34_44_35522="TEE left atrial myxoma 2";
var content_f34_44_35522=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/64739/teelatm2_conv.mp4?title=TEE+left+atrial+myxoma+2\" style=\"width:328px;height:248px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left atrial myxoma seen on TEE",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 441px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transesophageal echocardiogram shows a large left atrial myxoma adherent to the interatrial septum by a broad stalk. Part of the myxoma extends into the left ventricle during diastole.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35522=[""].join("\n");
var outline_f34_44_35522=null;
var title_f34_44_35523="Patient information: Polycystic kidney disease (The Basics)";
var content_f34_44_35523=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16253\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/28/27072\">",
"         Anatomy of the urinary tract",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?39/54/40804\">",
"          Organs inside the abdomen (belly)",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?22/59/23474\">",
"         Patient information: Blood in the urine (hematuria) in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?18/42/19107\">",
"         Patient information: Choosing between dialysis and kidney transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/35/28212\">",
"         Patient information: Chronic kidney disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?25/1/25619\">",
"         Patient information: Hemodialysis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?33/58/34722\">",
"         Patient information: High blood pressure in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?29/37/30290\">",
"         Patient information: High blood pressure in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?42/56/43905\">",
"         Patient information: Kidney stones in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?24/46/25315\">",
"         Patient information: Kidney transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?12/15/12531\">",
"         Patient information: Planning for a kidney transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?11/22/11619\">",
"         Patient information: Preparing for hemodialysis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/16/37121\">",
"         Patient information: What are clinical trials? (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?13/5/13398\">",
"         Patient information: Chronic kidney disease (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?9/26/9635\">",
"         Patient information: Dialysis or kidney transplantation &mdash; which is right for me? (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?39/57/40852\">",
"         Patient information: Hemodialysis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?32/54/33635\">",
"         Patient information: High blood pressure in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?37/28/38337\">",
"         Patient information: High blood pressure in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/53/28499\">",
"         Patient information: Kidney stones in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?37/24/38277\">",
"         Patient information: Polycystic kidney disease (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Polycystic kidney disease (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/polycystic-kidney-disease-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H1567774\">",
"      <span class=\"h1\">",
"       What is polycystic kidney disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Polycystic kidney disease (PKD) is a condition that affects the kidneys (",
"      <a class=\"graphic graphic_figure graphicRef79864 \" href=\"mobipreview.htm?26/28/27072\">",
"       figure 1",
"      </a>",
"      ). When people have PKD, abnormal fluid-filled sacs called &ldquo;cysts&rdquo; grow in the kidneys.",
"     </p>",
"     <p>",
"      The cysts cause the kidneys to get bigger than normal. The cysts can also keep the kidneys from working normally. This can lead to problems, such as high blood pressure, kidney infections, and kidney failure. Kidney failure is when the kidneys stop working completely. Besides kidney problems, PKD can cause problems in other parts of the body.",
"     </p>",
"     <p>",
"      PKD usually runs in families.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1567781\">",
"      <span class=\"h1\">",
"       What are the symptoms of PKD?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people with PKD have no symptoms. When people do have symptoms, they can have:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Pain in the lower half of the back or on the side, with or without a fever",
"       </li>",
"       <li>",
"        Pain in the belly",
"       </li>",
"       <li>",
"        Blood in the urine",
"       </li>",
"       <li>",
"        Kidney stones &mdash; These are small, stone-like objects that form inside the kidneys. They can cause belly or side pain, or blood in the urine.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      PKD can also cause problems in other parts of the body, such as:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A bulging blood vessel in the brain &mdash; If the blood vessel bursts, it can cause a sudden, severe headache and nausea and vomiting. A burst blood vessel can lead to brain damage and even death.",
"       </li>",
"       <li>",
"        Cysts in the liver (",
"        <a class=\"graphic graphic_figure graphicRef64960 \" href=\"mobipreview.htm?39/54/40804\">",
"         figure 2",
"        </a>",
"        ) &mdash; These can cause belly pain.",
"       </li>",
"       <li>",
"        A weak area in the belly muscles (called a &ldquo;hernia&rdquo;) &mdash; This can cause an area of the belly to bulge out.",
"       </li>",
"       <li>",
"        Heart problems &mdash; These do not usually cause symptoms.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1567788\">",
"      <span class=\"h1\">",
"       Is there a test for PKD?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. To find out if you have PKD, your doctor can do:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        An imaging test, such as an ultrasound, CT, or MRI scan &mdash; Imaging tests create pictures of the inside of the body.",
"       </li>",
"       <li>",
"        Blood tests to check for the abnormal genes that cause the disease",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1567795\">",
"      <span class=\"h1\">",
"       How is PKD treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors treat PKD by treating the symptoms and problems the disease causes.",
"     </p>",
"     <p>",
"      For example, doctors can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Treat high blood pressure with lifestyle changes, diet changes, and medicines &mdash; Treating high blood pressure can help the kidneys stay healthy for a longer time.",
"       </li>",
"       <li>",
"        Treat kidney infections with antibiotic medicines",
"       </li>",
"       <li>",
"        Treat pain with pain-relieving medicines",
"       </li>",
"       <li>",
"        Do surgery to fix a bulging blood vessel in the brain",
"       </li>",
"       <li>",
"        Do surgery to fix a hernia",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1567802\">",
"      <span class=\"h1\">",
"       What happens if my kidneys stop working completely?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your kidneys stop working completely, you will need treatment that takes over the job of your kidneys. Normally, the kidneys make urine by removing waste and excess salt and water from the blood.",
"     </p>",
"     <p>",
"      There are 2 treatments for people whose kidneys stop working completely. They are:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A procedure called dialysis &mdash; There are 2 types of dialysis, but most people with PKD have a type called &ldquo;hemodialysis.&rdquo; During hemodialysis, a machine removes waste and excess salt and water from the blood. People who get hemodialysis need to be hooked up to a machine for a few hours at least 3 times a week. They will need hemodialysis for the rest of their life or until they can get a kidney transplant. &nbsp; &nbsp;",
"       </li>",
"       <li>",
"        Kidney transplant surgery &mdash; During this surgery, a doctor replaces your diseased kidney with a healthy kidney. That way, the new kidney can do the job of your kidneys. (People need only 1 healthy kidney to live.)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you have questions about the different options, talk with your doctor or nurse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1567809\">",
"      <span class=\"h1\">",
"       Should my family members get tested?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have PKD, your adult family members should talk with their doctor about getting tested for it. There are benefits and downsides to getting tested.",
"     </p>",
"     <p>",
"      Doctors do not usually recommend that children get tested unless they have symptoms. But children should see their doctor or nurse every year to have their blood pressure checked.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1567816\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/59/23474?source=see_link\">",
"       Patient information: Blood in the urine (hematuria) in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/58/34722?source=see_link\">",
"       Patient information: High blood pressure in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/37/30290?source=see_link\">",
"       Patient information: High blood pressure in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?42/56/43905?source=see_link\">",
"       Patient information: Kidney stones in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/35/28212?source=see_link\">",
"       Patient information: Chronic kidney disease (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/1/25619?source=see_link\">",
"       Patient information: Hemodialysis (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/22/11619?source=see_link\">",
"       Patient information: Preparing for hemodialysis (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/15/12531?source=see_link\">",
"       Patient information: Planning for a kidney transplant (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/16/37121?source=see_link\">",
"       Patient information: What are clinical trials? (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/42/19107?source=see_link\">",
"       Patient information: Choosing between dialysis and kidney transplant (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/46/25315?source=see_link\">",
"       Patient information: Kidney transplant (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/24/38277?source=see_link\">",
"       Patient information: Polycystic kidney disease (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?32/54/33635?source=see_link\">",
"       Patient information: High blood pressure in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/28/38337?source=see_link\">",
"       Patient information: High blood pressure in children (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/53/28499?source=see_link\">",
"       Patient information: Kidney stones in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/5/13398?source=see_link\">",
"       Patient information: Chronic kidney disease (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/57/40852?source=see_link\">",
"       Patient information: Hemodialysis (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/26/9635?source=see_link\">",
"       Patient information: Dialysis or kidney transplantation &mdash; which is right for me? (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?34/44/35523?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16253 Version 4.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-219.243.220.100-C38B34FA94-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35523=[""].join("\n");
var outline_f34_44_35523=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1567774\">",
"      What is polycystic kidney disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1567781\">",
"      What are the symptoms of PKD?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1567788\">",
"      Is there a test for PKD?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1567795\">",
"      How is PKD treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1567802\">",
"      What happens if my kidneys stop working completely?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1567809\">",
"      Should my family members get tested?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1567816\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16253\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/28/27072\">",
"      Anatomy of the urinary tract",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?39/54/40804\">",
"       Organs inside the abdomen (belly)",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/59/23474?source=related_link\">",
"      Patient information: Blood in the urine (hematuria) in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/42/19107?source=related_link\">",
"      Patient information: Choosing between dialysis and kidney transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/5/13398?source=related_link\">",
"      Patient information: Chronic kidney disease (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/35/28212?source=related_link\">",
"      Patient information: Chronic kidney disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/26/9635?source=related_link\">",
"      Patient information: Dialysis or kidney transplantation &mdash; which is right for me? (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/57/40852?source=related_link\">",
"      Patient information: Hemodialysis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/1/25619?source=related_link\">",
"      Patient information: Hemodialysis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?32/54/33635?source=related_link\">",
"      Patient information: High blood pressure in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/58/34722?source=related_link\">",
"      Patient information: High blood pressure in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/28/38337?source=related_link\">",
"      Patient information: High blood pressure in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/37/30290?source=related_link\">",
"      Patient information: High blood pressure in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/53/28499?source=related_link\">",
"      Patient information: Kidney stones in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?42/56/43905?source=related_link\">",
"      Patient information: Kidney stones in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/46/25315?source=related_link\">",
"      Patient information: Kidney transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/15/12531?source=related_link\">",
"      Patient information: Planning for a kidney transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/24/38277?source=related_link\">",
"      Patient information: Polycystic kidney disease (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/22/11619?source=related_link\">",
"      Patient information: Preparing for hemodialysis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/16/37121?source=related_link\">",
"      Patient information: What are clinical trials? (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_44_35524="Pancrelipase: Patient drug information";
var content_f34_44_35524=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Pancrelipase: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/46/743?source=see_link\">",
"     see \"Pancrelipase: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/14/8422?source=see_link\">",
"     see \"Pancrelipase: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F206069\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Creon&reg;;",
"     </li>",
"     <li>",
"      Pancreaze&trade;;",
"     </li>",
"     <li>",
"      Pancrelipase&trade;;",
"     </li>",
"     <li>",
"      Pertzye&trade;;",
"     </li>",
"     <li>",
"      Ultresa&trade;;",
"     </li>",
"     <li>",
"      Viokace&trade;;",
"     </li>",
"     <li>",
"      Zenpep&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F206070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cotazym&reg;;",
"     </li>",
"     <li>",
"      Creon&reg;;",
"     </li>",
"     <li>",
"      Pancrease&reg; MT;",
"     </li>",
"     <li>",
"      Ultrase&reg;;",
"     </li>",
"     <li>",
"      Ultrase&reg; MT;",
"     </li>",
"     <li>",
"      Viokase&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022555\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022557\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691373",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help break down food when the pancreas is not working the right way.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022556\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to pancrelipase, pork, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is more than one brand of this drug. One brand cannot safely be used for the other. Your doctor will tell you about any needed change.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Watch for gout attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022562\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698108",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gas.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699033",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022559\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3890623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with meals and snacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Capsule:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2836486",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may sprinkle contents of capsule on applesauce. Do not chew. Swallow right away and follow with water or juice.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022560\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11241 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-07BE0D3610-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35524=[""].join("\n");
var outline_f34_44_35524=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206069\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206070\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022555\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022557\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022556\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022561\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022562\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022564\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022559\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022560\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022565\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022566\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?0/46/743?source=related_link\">",
"      Pancrelipase: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/14/8422?source=related_link\">",
"      Pancrelipase: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_44_35525="Diagnostic testing for HIV infection in infants and children younger than 18 months";
var content_f34_44_35525=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic testing for HIV infection in infants and children younger than 18 months",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35525/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35525/contributors\">",
"     Heidi Schwarzwald, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35525/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35525/contributors\">",
"     Mary E Paul, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35525/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35525/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/44/35525/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Readily available diagnostic tests that rely on detection of antibody to HIV virus are not reliable in infants and young children because of the persistence of transplacentally acquired maternal antibody. For this reason, more sophisticated and often more expensive testing is necessary to diagnose HIV infection in this population.",
"   </p>",
"   <p>",
"    This topic reviews the strategy for diagnosing HIV infection in infants and young children of mothers with known HIV infection or of uncertain HIV serostatus. The diagnosis of HIV infection in adults and older children (older than age 18 months) and strategies for preventing mother-to-child transmission (MTCT) of HIV are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/55/20345?source=see_link\">",
"     \"Diagnostic assays for HIV infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/23/29050?source=see_link\">",
"     \"Prevention of HIV transmission during breastfeeding in resource-limited settings\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/44/25290?source=see_link\">",
"     \"Use of antiretroviral medications in pregnant HIV-infected patients and their infants in resource-rich settings\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/4/15433?source=see_link\">",
"     \"Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NEED FOR EARLY DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Promptly establishing the diagnosis of HIV infection in infants and young children is important for several reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants who are infected with HIV have a better prognosis when highly active antiretroviral therapy (HAART) is started early.",
"     </li>",
"     <li>",
"      Prophylaxis for Pneumocystis carinii pneumonia (PCP, but officially renamed",
"      <em>",
"       Pneumocystis jirovecii",
"      </em>",
"      pneumonia) is recommended for infants who may be infected with HIV. Infants who are not infected can stop taking medications such as",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?40/23/41336?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      , reducing the risk for side effects.",
"     </li>",
"     <li>",
"      Families will generally be anxious for the results of definitive HIV testing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic tests for HIV are used routinely in adults and in children &ge;18 months and, other than in the first few weeks after infection, are highly sensitive and specific. Primary HIV infection in adults is typically diagnosed by performing an HIV virologic assay. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/55/20345?source=see_link\">",
"     \"Diagnostic assays for HIV infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/17/22808?source=see_link\">",
"     \"Acute and early HIV infection: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The situation in infants and young children is different for two main reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maternal HIV antibodies persist for many months. As an example, in a study of 271 children born to HIV-infected mothers, 234 uninfected, immunologically normal, well children were followed for over one year [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/1\">",
"       1",
"      </a>",
"      ]. The mean age of loss of maternal antibody was 10.3 months. One child did not lose maternal antibody until older than 18 months of age. Similarly, in a group of 79 uninfected infants born to mothers infected with HIV, maternal anti-HIV antibody decreased gradually over the first nine months of life [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      When antiretroviral therapy has been administered to the mother, either as treatment or to prevent mother-to-child transmission, and has also been administered as prophylaxis to the baby, an HIV viral load may be undetectable even in an infected infant.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For this reason, the standard test for HIV infection in infants and children who are younger than 18 months of age is HIV polymerase chain reaction (PCR) testing. Cord blood should not be used for testing because of the possibility of contamination of the sample with maternal blood. Repeat testing is necessary because HIV infection can occur perinatally and very recent infection will not be detectable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     HIV DNA PCR testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A qualitative HIV-1 DNA PCR assay that detects HIV proviral DNA within peripheral blood mononuclear cells is the primary test used for the diagnosis of HIV-1 infection in infants born to seropositive mothers in countries where the test is available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/3\">",
"     3",
"    </a>",
"    ]. The test should be positive in patients infected with HIV even while they are being treated with highly active antiretroviral therapy (HAART).",
"   </p>",
"   <p>",
"    Approximately two-thirds of mother-to-child transmission of HIV occurs perinatally, and DNA PCR testing will not detect very recent infection. The sensitivity of HIV-1 DNA PCR testing when performed at birth is 55 percent; it increases to &gt;90 percent by two to four weeks of age, and 100 percent at three and six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The specificity of HIV-1 DNA PCR is 99.8 percent at birth and 100 percent at one, three, and six months.",
"   </p>",
"   <p>",
"    In developed countries, DNA PCR is the preferred virologic method for establishing the diagnosis of HIV infection in infants and children younger than the age of 18 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HIV clade B is the predominant viral strain in the US. Non-clade-B strains are more prevalent in other parts of the world. For example, clade C predominates in Africa and India, and clade E in southeast Asia. Some currently used HIV DNA PCR assays may be less sensitive in detecting non-B clades [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/8-10\">",
"     8-10",
"    </a>",
"    ], but assays with greater sensitivity for non-B clades have been developed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     HIV RNA assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assays for HIV-1 RNA are the standard viral load tests performed for monitoring response to treatment of HIV infection. Studies have suggested that the sensitivity and specificity of HIV RNA testing for neonatal HIV infection are at least as good as that of HIV DNA testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/4-6,11-13\">",
"     4-6,11-13",
"    </a>",
"    ]. However, these studies were not performed in children born to mothers who were receiving HAART. HAART could be expected to lead to an undetectable viral load measurement, and thus a negative HIV-1 RNA test. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/44/39623?source=see_link\">",
"     \"Techniques and interpretation of HIV-1 RNA quantitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HIV RNA assays have a role in the evaluation of children born in the United States to mothers with HIV who are likely to be infected with subtypes of HIV other than clade B (eg, immigrants from Africa), since the HIV DNA PCR tests commonly available in the United States are less sensitive for non-clade-B strains of HIV. RNA assays using branched DNA technology, as well as the Amplicor 1.5 RNA assay, are relatively sensitive for non-clade-B HIV. APTIMA&reg; HIV-1 RNA Qualitative Assay (Gen-Probe Incorporated San Diego, CA) is capable of sensitive detection of all the major HIV-1 genetic variants. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'HIV DNA PCR testing'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/44/39623?source=see_link&amp;anchor=H10#H10\">",
"     \"Techniques and interpretation of HIV-1 RNA quantitation\", section on 'HIV-1 subtypes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other tests have been used to detect HIV viral infection.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HIV-1 peripheral blood cell culture is expensive and not widely available, and results take a long time (up to four weeks) to become available [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/3,7,14\">",
"       3,7,14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      HIV-1 p24 antigen assays have low sensitivity in infants less than six months of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These tests are not recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/3,7,15\">",
"     3,7,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC STRATEGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to the diagnosis of HIV in infants and young children (younger than 18 months of age) depends on whether the HIV status of the mother is known [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/3\">",
"     3",
"    </a>",
"    ]. The following recommendations for establishing the diagnosis of HIV infection in infants and young children are based on CDC and American Academy of Pediatrics (AAP) guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/3,7,15\">",
"     3,7,15",
"    </a>",
"    ]. These guidelines also outline standard procedures for obtaining consent and for counseling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Maternal HIV status unknown",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the maternal HIV status is unknown, serologic testing for HIV should be performed on the mother or infant. The results of serologic testing, whether of the mother or infant, reflect the HIV status of the mother, not the infant, since it is maternal antibodies to HIV that will be detected. In 2006, the CDC recommended that all pregnant women should be tested for HIV. Separate written consent is not required. The mother should be tested after being informed about the test, unless she specifically refuses (\"opts out\") [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/34/10793?source=see_link&amp;anchor=H12#H12\">",
"     \"Serologic screening for HIV infection\", section on 'Opt-out testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If serologic testing for HIV is positive, testing of the infant should proceed as below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     HIV-infected mother",
"    </span>",
"    &nbsp;&mdash;&nbsp;In an infant or young child born to an HIV-infected mother, testing is performed with an HIV DNA PCR test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/7\">",
"     7",
"    </a>",
"    ]. When testing is completed depends upon maternal prenatal care.",
"   </p>",
"   <p>",
"    If the mother received appropriate antiretroviral treatment and the infant is at LOW risk for acquiring HIV, testing should be performed at 14 to 21 days, one to two months, and four to six months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/7\">",
"     7",
"    </a>",
"    ]. A positive result at any point should be confirmed as soon as possible with a repeat virologic test.",
"   </p>",
"   <p>",
"    An infant born to a mother who did not receive standard care for an HIV-infected pregnant woman or who was diagnosed with acute HIV during pregnancy should be tested at birth, as well as 14 to 21 days, one to two months, and four to six months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/7\">",
"     7",
"    </a>",
"    ]. This permits determination of timing of the infection if the infant is infected. A positive result within the first three days of life reflects HIV infection in utero, while infants who have a negative initial test but test positive on subsequent tests were presumably infected peripartum. A positive result at any point should be confirmed as soon as possible with a repeat virologic test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Definitive exclusion of HIV infection in non-breastfed infants is based on two or more negative virologic tests (one obtained at &ge;1 month of age and one at &ge;4 months of age) or two negative antibody tests from separate specimens obtained at &ge;6 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/7\">",
"     7",
"    </a>",
"    ]. Some experts recommend a follow up antibody test at 12 to 18 months of age to document clearance of maternal antibody and confirm the child&rsquo;s HIV-negative status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An alternative to HIV DNA PCR in babies born to mothers who were not treated with antiretroviral medication and who have not themselves received antiretroviral medication is to perform an HIV RNA assay. As an example, the six-month-old infant of a mother who has been newly diagnosed with HIV can be tested for HIV by performing an HIV viral load. A viral load greater than 5000",
"    <span class=\"nowrap\">",
"     copies/mL",
"    </span>",
"    indicates infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35525/abstract/7\">",
"     7",
"    </a>",
"    ]. Lower positive results may be false positives and require confirmation with another test. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'HIV RNA assays'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In the United States, when evaluating infants and young children born to mothers who are likely to be infected with a strain of HIV other than clade B (eg, mother immigrated from Africa), in addition to performing the commonly available HIV DNA PCR test, the clinician should test the child with an HIV RNA assay that is sensitive for non-clade-B strains of HIV. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'HIV RNA assays'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSIS IN CHILDREN OLDER THAN 18 MONTHS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of HIV infection in children with perinatal exposure who are older than 18 months, in children with nonperinatal exposure, and adults is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/55/20345?source=see_link\">",
"     \"Diagnostic assays for HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Readily available diagnostic tests that rely on detection of antibody to HIV virus are not reliable in infants and children younger than 18 months of age because of the persistence of transplacentally acquired maternal antibody. Virologic tests are required in babies born to HIV-infected mothers. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the maternal HIV status is unknown, serologic testing for HIV should be performed on the mother or infant. If the serologic test is positive, proceed with virologic testing of the infant as for the infant of an HIV-infected mother. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Maternal HIV status unknown'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In an infant or young child born to an HIV-infected mother, an HIV DNA PCR assay of peripheral blood mononuclear cells is the preferred test for HIV. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'HIV-infected mother'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If the mother received appropriate antiretroviral treatment and the infant is at LOW risk for acquiring HIV, testing should be performed at 14 to 21 days, one to two months, and four to six months of age. A positive result at any point should be confirmed as soon as possible with a repeat virologic test.",
"     </li>",
"     <li>",
"      An infant born to a mother who did not receive standard care for an HIV-infected pregnant woman or a woman who was diagnosed with acute HIV during pregnancy should be tested at birth, as well as 14 to 21 days, one to two months, and four to six months of age. A positive result at any point should be confirmed as soon as possible with a repeat virologic test.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Definitive exclusion of HIV infection in nonbreastfed infants requires at least two negative virologic tests: one at &ge;1 month of age and one at &ge;4 months of age. Some experts recommend a follow up antibody test at 12 to 18 months of age to document clearance of maternal antibody and confirm the child&rsquo;s HIV-negative status. Children born to a mother in the United States who is likely to be infected with a non-clade-B strain of HIV (eg, immigrant from Africa) should be tested with an HIV RNA assay that is sensitive for non-clade-B strains of HIV in parallel with the HIV DNA PCR testing in the preceding bullet. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'HIV RNA assays'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'HIV-infected mother'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/1\">",
"      Mother-to-child transmission of HIV infection. The European Collaborative Study. Lancet 1988; 2:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/2\">",
"      Louisirirotchanakul S, Kanoksinsombat C, Likanonsakul S, et al. Patterns of anti-HIV IgG3, IgA and p24Ag in perinatally HIV-1 infected infants. Asian Pac J Allergy Immunol 2002; 20:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/3\">",
"      Read JS, Committee on Pediatric AIDS, American Academy of Pediatrics. Diagnosis of HIV-1 infection in children younger than 18 months in the United States. Pediatrics 2007; 120:e1547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/4\">",
"      Havens PL, Mofenson LM, American Academy of Pediatrics Committee on Pediatric AIDS. Evaluation and management of the infant exposed to HIV-1 in the United States. Pediatrics 2009; 123:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/5\">",
"      American Academy of Pediatrics Committee on Pediatric AIDS. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. Pediatrics 2008; 122:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/6\">",
"      Burgard M, Blanche S, Jasseron C, et al. Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis. J Pediatr 2012; 160:60.",
"     </a>",
"    </li>",
"    <li>",
"     Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children.",
"Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. file://aidsinfo.nih.gov/contentfiles/lvguidelines/pediatricguidelines.pdf (Accessed on November 02, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/8\">",
"      Kline NE, Schwarzwald H, Kline MW. False negative DNA polymerase chain reaction in an infant with subtype C human immunodeficiency virus 1 infection. Pediatr Infect Dis J 2002; 21:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/9\">",
"      Haas J, Geiss M, B&ouml;hler T. False-negative polymerase chain reaction-based diagnosis of human immunodeficiency virus (HIV) type 1 in children infected with HIV strains of African origin. J Infect Dis 1996; 174:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/10\">",
"      Zaman MM, Recco RA, Haag R. Infection with non-B subtype HIV type 1 complicates management of established infection in adult patients and diagnosis of infection in newborn infants. Clin Infect Dis 2002; 34:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/11\">",
"      Young NL, Shaffer N, Chaowanachan T, et al. Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. J Acquir Immune Defic Syndr 2000; 24:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/12\">",
"      Nesheim S, Palumbo P, Sullivan K, et al. Quantitative RNA testing for diagnosis of HIV-infected infants. J Acquir Immune Defic Syndr 2003; 32:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/13\">",
"      Lambert JS, Harris DR, Stiehm ER, et al. Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection. J Acquir Immune Defic Syndr 2003; 34:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/14\">",
"      Hollinger FB, Bremer JW, Myers LE, et al. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories. J Clin Microbiol 1992; 30:1787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/15\">",
"      King SM, American Academy of Pediatrics Committee on Pediatric AIDS, American Academy of Pediatrics Infectious Diseases and Immunization Committee. Evaluation and treatment of the human immunodeficiency virus-1--exposed infant. Pediatrics 2004; 114:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35525/abstract/16\">",
"      Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6006 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-89.32.226.102-9F539080E8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35525=[""].join("\n");
var outline_f34_44_35525=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NEED FOR EARLY DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSTIC TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HIV DNA PCR testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HIV RNA assays",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSTIC STRATEGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Maternal HIV status unknown",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      HIV-infected mother",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSIS IN CHILDREN OLDER THAN 18 MONTHS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/17/22808?source=related_link\">",
"      Acute and early HIV infection: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/55/20345?source=related_link\">",
"      Diagnostic assays for HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/4/15433?source=related_link\">",
"      Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/23/29050?source=related_link\">",
"      Prevention of HIV transmission during breastfeeding in resource-limited settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/34/10793?source=related_link\">",
"      Serologic screening for HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/44/39623?source=related_link\">",
"      Techniques and interpretation of HIV-1 RNA quantitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/44/25290?source=related_link\">",
"      Use of antiretroviral medications in pregnant HIV-infected patients and their infants in resource-rich settings",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_44_35526="Pityriasis rubra pilaris";
var content_f34_44_35526=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythroderma in pityriasis rubra pilaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diffuse erythroderma with characteristic islands of sparing in a patient with pityriasis rubra pilaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35526=[""].join("\n");
var outline_f34_44_35526=null;
var title_f34_44_35527="LCDD in liver Light";
var content_f34_44_35527=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F71088%7ENEPH%2F59302&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F71088%7ENEPH%2F59302&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light chain deposition disease in the liver",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 394px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medium power view of an immunoperoxidase stain of a liver biopsy shows kappa light chain deposition in a patient with light chain deposition disease. A stain for lambda light chains was negative.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light chain deposition disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 248px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immunofluorescence microscopy using anti-kappa light chain antiserum on a liver biopsy from a patient with light chain deposition disease. There is diffuse deposition of kappa light chains. A stain for lambda light chains was negative.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35527=[""].join("\n");
var outline_f34_44_35527=null;
var title_f34_44_35528="Clinical manifestations and diagnosis of autoimmune hepatitis";
var content_f34_44_35528=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of autoimmune hepatitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35528/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35528/contributors\">",
"     Michael A Heneghan, MD, MMedSc, FRCPI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35528/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35528/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35528/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35528/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/44/35528/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoimmune hepatitis is a chronic hepatitis that occurs in children and adults of all ages. It is characterized by immunologic and autoimmunologic features, generally including the presence of circulating autoantibodies and high serum globulin concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/1\">",
"     1",
"    </a>",
"    ]. Since it was first described in the 1950s, the disorder has been known by a variety of terms, including active chronic hepatitis, chronic active hepatitis, chronic aggressive hepatitis, lupoid hepatitis, plasma cell hepatitis, and, most commonly, autoimmune chronic active hepatitis. In 1992, the International Autoimmune Hepatitis Group recommended autoimmune hepatitis as the most appropriate and least redundant term for this disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type 1 autoimmune hepatitis &ndash; Type 1, or classic autoimmune hepatitis, is characterized by circulating antibodies to nuclei (ANA)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      smooth muscle (ASMA); the latter are thought to be reflective of more specific antiactin antibodies (AAA). AAA is not generally measured in most clinical laboratories, but ASMA with titers of 1:320 or greater generally reflect the presence of AAA. An ELISA technique for detecting antiactin antibodies (IgG anti F-actin) is available in some laboratories and is being used more frequently in commercial laboratories in North America. Other autoantibodies can occur in conjunction with or independent of ANA and ASMA. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Autoantibodies'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42902?source=see_link\">",
"       \"Serologic markers of autoimmune hepatitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Type 2 autoimmune hepatitis &ndash; Type 2 autoimmune hepatitis is defined by the presence of antibodies to",
"      <span class=\"nowrap\">",
"       liver/kidney",
"      </span>",
"      microsomes (ALKM-1)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      to a liver cytosol antigen (ALC-1) (",
"      <a class=\"graphic graphic_table graphicRef65135 \" href=\"mobipreview.htm?8/0/8203\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical manifestations of autoimmune hepatitis will be reviewed here. The treatment of this disorder is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40058?source=see_link\">",
"     \"Treatment of autoimmune hepatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1061186526\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoimmune hepatitis is seen in all ethnic groups and can occur at any age, though it is often diagnosed in patients in their 40s or 50s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. It is more common in women than in men (female to male ratio of 3.6 to 1). In studies from Europe, the incidence is 0.9 to 2 per 100,000 population per year, with a prevalence of 11 to 25 per 100,000 population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/4-7\">",
"     4-7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoimmune hepatitis has a heterogeneous and fluctuating nature, leading to marked variability in its clinical manifestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/1,8\">",
"     1,8",
"    </a>",
"    ]. The spectrum includes asymptomatic patients, those with considerable and sometimes debilitating symptoms, and those with acute liver failure. Furthermore, long periods of subclinical disease may occur before or after presentation. Physical findings range from a normal physical examination to the presence of hepatomegaly, splenomegaly, stigmata of chronic liver disease, and jaundice.",
"   </p>",
"   <p>",
"    Asymptomatic patients may be identified when they undergo routine screening examinations, such as those required for entrance to schools, for employment, or prior to blood donation. In this setting, the finding of an elevated aminotransferase level may be the only clue to the presence of liver disease. On occasion, the asymptomatic patient is discovered when abdominal surgery is performed for some other reason and the surgeon notes an abnormal, sometimes frankly cirrhotic-appearing liver.",
"   </p>",
"   <p>",
"    At the far end of the spectrum are those patients who present acutely, sometimes with acute liver failure, perhaps with profound jaundice, an elevated prothrombin time, and aminotransferase values &gt;1000",
"    <span class=\"nowrap\">",
"     U/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/9\">",
"     9",
"    </a>",
"    ]. Such a presentation is uncommon with autoimmune hepatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/10\">",
"     10",
"    </a>",
"    ]. The presence of infiltrate in the portal areas and plasma cell infiltrates can help distinguish such patients from those with other forms of acute hepatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Many patients with an acute presentation have established cirrhosis when biopsied. Thus, they must have had subclinical disease for some period of time. One report found that patients with an acute onset were significantly older than those with a more chronic presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/13\">",
"     13",
"    </a>",
"    ]. The duration of the subclinical anicteric course is generally difficult to ascertain. In some cases, in retrospect, a previous fluctuating course can be identified which had been thought to reflect some other disease.",
"   </p>",
"   <p>",
"    In addition to asymptomatic disease and a sudden presentation, some patients present with a variety of mild or severe nonspecific symptoms, such as fatigue, lethargy, malaise, anorexia, nausea, abdominal pain, and itching. Although not specific to autoimmune hepatitis, arthralgia involving the small joints is a characteristic clinical feature.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Extrahepatic manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;One clue to diagnosing autoimmune hepatitis may be the coexistence of other diseases with autoimmune features. In the spectrum of autoimmune disease, classified from organ-specific to non-organ-specific, autoimmune liver diseases fall somewhere in the middle. The disease is usually confined to the liver but can be associated with a number of other autoimmune diseases.",
"   </p>",
"   <p>",
"    Diseases commonly seen with autoimmune hepatitis include hemolytic anemia, idiopathic thrombocytopenic purpura, type 1 diabetes mellitus, thyroiditis, celiac sprue, and ulcerative colitis (which is more often associated with primary sclerosing cholangitis). The liver disease may antedate the appearance of colitis in both disorders. In addition, a polyglandular autoimmune syndrome can occur in children with type 2 autoimmune hepatitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/4/31812?source=see_link\">",
"     \"Extrahepatic manifestations of autoimmune hepatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complications of autoimmune hepatitis are those seen in any progressive liver disease and occur in patients with untreated or unresponsive disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40058?source=see_link\">",
"     \"Treatment of autoimmune hepatitis\"",
"    </a>",
"    .) Primary hepatocellular carcinoma is thought to be a natural consequence of the chronic hepatitis-cirrhosis disease progression. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/38/25194?source=see_link\">",
"     \"Epidemiology and etiologic associations of hepatocellular carcinoma\"",
"    </a>",
"    .) Autoimmune hepatitis is not an exception to this hypothesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/14-16\">",
"     14-16",
"    </a>",
"    ], although progression to carcinoma is less frequent than in chronic viral hepatitis.",
"   </p>",
"   <p>",
"    On occasion, patients with autoimmune hepatitis and hepatocellular carcinoma have hepatitis C as a complicating condition, making the association with autoimmune hepatitis uncertain. In addition,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    and other immunosuppressive agents may have a role in the development of some malignancies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/2/44074?source=see_link\">",
"     \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\"",
"    </a>",
"    .) One report found an increased risk of nonmelanoma skin cancer in patients with autoimmune hepatitis treated with long-term immunosuppression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis is based upon characteristic serologic and histologic findings and the exclusion of other forms of chronic liver disease. It can often be strongly suspected based upon clinical and laboratory features, and thus a liver biopsy may not always be necessary in patients with typical findings on noninvasive testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/18\">",
"     18",
"    </a>",
"    ]. Guidelines issued by the American Association for the Study of Liver Diseases in 2010 suggest the following diagnostic considerations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis should be made in patients with compatible clinical signs, symptoms, and laboratory abnormalities. Compatible laboratory and histological abnormalities include abnormal liver biochemical tests, an increased total IgG or gamma-globulin levels, serologic markers (ANA, SMA, anti-LKM-1, or anti-LC1), and interface hepatitis. Other conditions that can cause chronic hepatitis should be excluded.",
"     </li>",
"     <li>",
"      In unclear cases (such as those who have few or atypical findings), a standardized scoring system should be used in the assessment. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Scoring systems'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      In those who are negative for conventional autoantibodies, additional autoantibodies should be sought. At minimum, this should include anti-SLA and atypical pANCA.",
"     </li>",
"     <li>",
"      Cholangiographic studies should be considered to exclude primary sclerosing cholangitis in adults who do not respond to corticosteroid therapy after three months.",
"     </li>",
"     <li>",
"      In children, cholangiographic studies should be considered to exclude autoimmune sclerosing cholangitis.",
"     </li>",
"     <li>",
"      All patients with autoimmune hepatitis and inflammatory bowel disease should undergo cholangiographic studies to exclude primary sclerosing cholangitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Laboratory features",
"    </span>",
"    &nbsp;&mdash;&nbsp;As a general rule, aminotransferase elevations are more striking in autoimmune hepatitis than those of bilirubin and alkaline phosphatase.",
"   </p>",
"   <p>",
"    In some cases, however, autoimmune hepatitis has a cholestatic picture marked by high levels of conjugated bilirubin and alkaline phosphatase. Extrahepatic obstruction (diagnosed by imaging studies), and cholestatic forms of viral hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, and the variant syndromes must be considered in this setting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/32/27140?source=see_link\">",
"     \"Classification of autoimmune hepatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One characteristic laboratory feature of autoimmune hepatitis, although not universally present, is an elevation in serum globulins, particularly gamma globulins and, generally, IgG (",
"    <a class=\"graphic graphic_figure graphicRef74708 \" href=\"mobipreview.htm?18/4/18510\">",
"     figure 1",
"    </a>",
"    ). Hyperglobulinemia is generally associated with circulating autoantibodies, which are particularly helpful in identifying autoimmune hepatitis. On the other hand, partial IgA deficiency is seen particularly in children with both type 1 and, more frequently, type 2 disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoimmune hepatitis is a chronic necroinflammatory disorder characterized histologically by the following nonspecific findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A portal mononuclear cell infiltrate, generally lymphoplasmacytic, often with occasional eosinophils, invades the sharply demarcated hepatocyte boundary (limiting plate) surrounding the portal triad and percolates into the surrounding lobule (periportal infiltrate) and beyond (",
"      <a class=\"graphic graphic_picture graphicRef67909 \" href=\"mobipreview.htm?7/41/7830\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The periportal lesion, sometimes referred to as piecemeal necrosis or interface hepatitis, essentially spares the biliary tree but may involve more of the lobule (",
"      <a class=\"graphic graphic_picture graphicRef67959 \" href=\"mobipreview.htm?43/7/44150\">",
"       picture 2",
"      </a>",
"      ). There may also be centrizonal necrosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bile duct changes (destructive and nondestructive cholangitis and ductopenia) are present in approximately 25 percent of patients. Granulomas are uncommonly seen.",
"     </li>",
"     <li>",
"      An exuberant plasma cell infiltrate, which in the past led to the use of the term plasma cell hepatitis, rosettes of hepatocytes, and multinucleated giant cells, may be seen (",
"      <a class=\"graphic graphic_picture graphicRef69850 \" href=\"mobipreview.htm?33/51/34614\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Fibrosis is present in all but the mildest forms of autoimmune hepatitis. Advanced fibrosis connects portal and central areas (bridging), which ultimately, by architectural distortion of the hepatic lobule and the appearance of regenerating nodules, results in cirrhosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The nonspecific nature of the histologic changes makes the measurement of autoantibodies and IgG or gamma globulin an important part of the diagnostic approach to autoimmune hepatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Autoantibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, the circulating autoantibodies commonly seen in type 1 autoimmune hepatitis are antinuclear, anti-smooth muscle,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    antiactin antibodies. On occasion, antimitochondrial antibodies occur in autoimmune hepatitis, [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/3,20\">",
"     3,20",
"    </a>",
"    ]. The characteristics of the major autoantibodies are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42902?source=see_link\">",
"     \"Serologic markers of autoimmune hepatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antiactin antibody measurements have not been generally performed in clinical laboratories in North America, but anti-smooth muscle antibody titers of 1:320 or greater generally reflect the presence of antiactin antibodies and can serve as a surrogate marker for these antibodies.",
"   </p>",
"   <p>",
"    An ELISA technique for detecting antiactin antibodies (F-actin ELISA) is commercially available in some regions. In one study, F-actin ELISA were significantly more sensitive than SMA titers (74 versus 34 percent) and similarly specific (98 versus 99 percent) in detecting AIH hepatitis in patients with various forms of chronic liver disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/21\">",
"     21",
"    </a>",
"    ]. Because the simplified criteria for the diagnosis of autoimmune hepatitis use autoantibodies measured by immunofluorescence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/22\">",
"     22",
"    </a>",
"    ], application of these criteria needs to be adapted to correspond to immunofluorescence titers.",
"   </p>",
"   <p>",
"    Approximately 30 percent of patients with type 1 autoimmune hepatitis have antibodies directed against a soluble liver antigen (anti",
"    <span class=\"nowrap\">",
"     SLA/LP).",
"    </span>",
"    Cytokeratins 8 and 18, subunits of glutathione S-transferases, and an as yet unidentified 50 kD protein were thought to be candidate antigens, but subsequent cloning and characterization of the antigen revealed that it is a unique enzyme (possibly a UGA-suppressor or tRNA-associated protein) and a member of the superfamily of pyridoxal phosphate-dependent transferases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. This antibody appears to be identical to the anti liver-pancreas protein (thus the designation anti",
"    <span class=\"nowrap\">",
"     SLA/LP)",
"    </span>",
"    and is of the IgG1 subtype, suggesting that it may arise from a specific immune stimulus such as a viral protein. However, no homologous virus-derived peptides could be identified in one report [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/25\">",
"     25",
"    </a>",
"    ]. These antibodies may be helpful diagnostically in patients without ANA or ASMA. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/8/19590?source=see_link\">",
"     \"Pathogenesis of autoimmune hepatitis\"",
"    </a>",
"    .) They occur in 10 to 30 percent of adults and in about 60 percent of children with AIH.",
"   </p>",
"   <p>",
"    Patients with ANA positive type 1 autoimmune hepatitis also may have other autoantibodies, including those directed against single-stranded (anti-ssDNA) and double-stranded (anti-dsDNA) DNA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/26\">",
"     26",
"    </a>",
"    ]. Atypical perinuclear antineutrophil cytoplasmic antibodies (P-ANCA), which are found in high frequency in primary sclerosing cholangitis and idiopathic ulcerative colitis, are also common in type 1 autoimmune hepatitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42902?source=see_link\">",
"     \"Serologic markers of autoimmune hepatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/28/9674?source=see_link\">",
"     \"Clinical spectrum of antineutrophil cytoplasmic antibodies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In type 2 autoimmune hepatitis, ALKM-1 antibodies occur alone or accompanied by ALC-1 (LC1) antibodies or rarely ANA. However, some patients have only ALC-1 antibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/27\">",
"     27",
"    </a>",
"    ]. As noted, anti",
"    <span class=\"nowrap\">",
"     SLA/LP",
"    </span>",
"    are common in children.",
"   </p>",
"   <p>",
"    There are some patients who present with all the features of autoimmune hepatitis but lack circulating ANA, ASMA, anti",
"    <span class=\"nowrap\">",
"     SLA/LP,",
"    </span>",
"    ANCA, or ALKM-1 antibodies. These patients may be more easily identified in the future as having autoimmune hepatitis when assays for other characteristic antibodies in this disorder become available. At present, they are considered to have cryptogenic chronic hepatitis or cryptogenic cirrhosis. A therapeutic response to anti-inflammatory therapy may be the only indication that autoimmune hepatitis is the underlying disease in these patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40058?source=see_link\">",
"     \"Treatment of autoimmune hepatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Scoring systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;A scoring system developed and subsequently revised by the International Autoimmune Hepatitis Group to standardize the diagnosis for population studies and clinical trials has had limited value in individual patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/2,28\">",
"     2,28",
"    </a>",
"    ]. A less complicated system using simplified criteria to be used in individual patients is based upon titers of autoantibodies, IgG levels, liver histology, and the exclusion of viral hepatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autoantibodies: assign one point if the ANA or SMA are 1:40 OR assign two points if the ANA or SMA are &ge;1:80 (OR if the LKM &ge;1:40 OR if the SLA is positive).",
"     </li>",
"     <li>",
"      IgG: assign one point if the IgG is &gt; the upper limit of normal OR assign two points if the IgG is &gt;1.10 times the upper limit of normal.",
"     </li>",
"     <li>",
"      Liver histology (evidence of hepatitis is a mandatory condition): assign one point if the histological features are compatible with autoimmune hepatitis OR two points if the histological features are typical of autoimmune hepatitis. Typical histologic features were defined as the presence of interface hepatitis,",
"      <span class=\"nowrap\">",
"       lymphocytic/lymphoplasmacytic",
"      </span>",
"      infiltrates in the portal tracts and extending into the lobule, emperipolesis (active penetration of one cell into and through a large cell), and hepatic rosette formation. Compatible features were defined as a picture of chronic hepatitis with lymphocytic infiltration without all the features considered typical.",
"     </li>",
"     <li>",
"      Absence of viral hepatitis: assign two points if viral hepatitis has been excluded. In the validation study, patients were mainly tested for hepatitis B and C. However, other forms of hepatitis should be considered depending upon the clinical setting.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A probable diagnosis of autoimmune hepatitis is made if the total points are six, while a definite diagnosis is made if the total points are &ge;seven.",
"   </p>",
"   <p>",
"    In a validation study involving 11 international centers, the simplified scoring system had 88 percent sensitivity and 97 percent specificity compared with a clinical and histologic reference standard when using a cutoff of &ge;six; the corresponding values were 81 and 99 percent, respectively, when using a cutoff of &ge;seven [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/22\">",
"     22",
"    </a>",
"    ]. Sensitivity was somewhat lower, but specificity remained high in a later validation study using a cutoff of &ge;seven (70 and 100 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A potential limitation of the scoring system is the relative lack of standardization of some of the autoantibody tests across testing facilities. Nevertheless, in the validation studies above, the local standards for autoantibody testing at each center were used, suggesting that the model is relatively robust to these differences. Whether probable and definite autoimmune hepatitis (as assessed by response to treatment) represent valid, discreet categories is also uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, the ability of the score to distinguish autoimmune hepatitis from autoimmune hepatitis overlap syndromes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/31\">",
"     31",
"    </a>",
"    ] will require further study. On the other hand, the score might help identify patients with overlap who have a treatable autoimmune component. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/4/35911?source=see_link\">",
"     \"Definition and treatment of variants of autoimmune hepatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The validation study did not include patients with drug-induced hepatitis, Wilson disease, genetic hemochromatosis, or alpha 1-antitrypsin deficiency, conditions that may share histologic features with autoimmune hepatitis. Thus, the score should be used in conjunction with the differential diagnosis.",
"   </p>",
"   <p>",
"    Finally, although the presence of autoantibodies is included in the scoring system, their absence does not indicate a decreased likelihood of responding to therapy. This was illustrated in a report of 52 patients with autoimmune hepatitis based upon the scoring system, of whom 10 (19 percent) were seronegative [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/32\">",
"     32",
"    </a>",
"    ]. The prevalence of ANAs or ASMAs did not correlate with the clinical or histologic severity of autoimmune hepatitis or the response to immunosuppressive therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of autoimmune hepatitis includes conditions associated with a chronic necroinflammatory picture that is often accompanied by fibrosis or cirrhosis (",
"    <a class=\"graphic graphic_table graphicRef63858 \" href=\"mobipreview.htm?39/27/40379\">",
"     table 2",
"    </a>",
"    ). The distinction between autoimmune hepatitis and the other autoimmune liver diseases, primary biliary cirrhosis and primary sclerosing cholangitis, and overlap syndromes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/31\">",
"     31",
"    </a>",
"    ] is generally based upon clinical, histologic, and immunologic features.",
"   </p>",
"   <p>",
"    Primary biliary cirrhosis and primary sclerosing cholangitis may at times be indistinguishable from autoimmune hepatitis on liver biopsy, but commonly have features involving bile duct paucity, inflammation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    damage, or periductular fibrosis that are not seen in autoimmune hepatitis (",
"    <a class=\"graphic graphic_picture graphicRef54128 graphicRef66904 graphicRef81040 \" href=\"mobipreview.htm?40/33/41498\">",
"     picture 4A-C",
"    </a>",
"    ). An evaluation of the autoantibody profile also may be helpful. Although antimitochondrial antibodies (AMA) can occur in association with other autoantibodies in autoimmune hepatitis, the isolated presence of AMA usually signifies primary biliary cirrhosis. However, there have been rare instances in which AMA is the sole autoantibody seen in autoimmune hepatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/31\">",
"     31",
"    </a>",
"    ]. The presence of AMA in patients with AIH does not appear to impact the natural history or response to treatment. On the other hand, a subset of patients with apparent autoimmune hepatitis and AMA eventually develop PBC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/33\">",
"     33",
"    </a>",
"    ]. Thus, such patients should be monitored.",
"   </p>",
"   <p>",
"    The diagnosis of variant or overlap syndromes of primary biliary",
"    <span class=\"nowrap\">",
"     cirrhosis/autoimmune",
"    </span>",
"    hepatitis and primary sclerosing",
"    <span class=\"nowrap\">",
"     cholangitis/autoimmune",
"    </span>",
"    hepatitis (the latter known as autoimmune sclerosing cholangitis in children) can be difficult [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/3,31\">",
"     3,31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/4/35911?source=see_link\">",
"     \"Definition and treatment of variants of autoimmune hepatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many of the features seen in autoimmune hepatitis may also occur in acute or chronic viral hepatitis, drug-associated chronic hepatitis, and a variety of other disorders (",
"    <a class=\"graphic graphic_table graphicRef63858 \" href=\"mobipreview.htm?39/27/40379\">",
"     table 2",
"    </a>",
"    ). As an example, the presence of hyperglobulinemia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    autoantibodies in chronic viral hepatitis (in which clinical and histopathological features may be identical to those in autoimmune hepatitis) may present a diagnostic dilemma.",
"   </p>",
"   <p>",
"    Various autoantibodies have been described in patients with fulminant hepatic failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Thus, their presence alone in such patients does not establish autoimmune hepatitis as the cause.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Acute hepatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the acute setting, it is necessary to distinguish autoimmune hepatitis from acute viral hepatitis secondary to hepatitis A to D, hepatitis E in some parts of the world, cytomegalovirus, Epstein-Barr virus, and herpes viruses. However, antibodies to hepatitis C virus may not develop until 6 to 12 months after infection; as a result, a measurement of circulating hepatitis C virus RNA (eg, by polymerase chain reaction or other technique) is required to rule out hepatitis C. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/55/41849?source=see_link\">",
"     \"Screening for and diagnosis of chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Chronic hepatitis C",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nonspecific antibody response seen in some patients with autoimmune hepatitis may make it difficult to distinguish between autoimmune diseases and chronic hepatitis C. Methods are now available to measure circulating hepatitis C RNA; as a result, patients with autoimmune hepatitis who have false positive hepatitis C antibodies can be identified. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/55/41849?source=see_link\">",
"     \"Screening for and diagnosis of chronic hepatitis C virus infection\"",
"    </a>",
"    .) On the other hand, patients with chronic hepatitis C may make a variety of autoantibodies including rheumatoid factor and cryoglobulins; the presence of these autoantibodies does not imply the existence of autoimmune liver disease. In rare instances, chronic viral hepatitis and autoimmune hepatitis coexist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 5 percent of patients in the United States and France with chronic hepatitis C have ANA or ASMA titers of 1:100 or greater. In some European countries, but apparently not the United States, ALKM-1 occurs with a similar or greater frequency in patients with chronic hepatitis C [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/37\">",
"     37",
"    </a>",
"    ]. One possible method of determining whether the hepatitis is primarily due to HCV or to autoimmune hepatitis is that the anti-LKM-1 antibodies in patients with HCV are directed at different epitopes of cytochrome P450 2D6 (CYP2D6, the target antigen) from that seen with autoimmune hepatitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42902?source=see_link\">",
"     \"Serologic markers of autoimmune hepatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Other forms of chronic hepatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic hepatitis from other causes must be distinguished from autoimmune hepatitis using available clinical data since there are no histological features that are specific for autoimmune hepatitis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rarely, autoimmune hepatitis occurs in conjunction with one of the disorders listed in the table, such as chronic viral hepatitis (",
"      <a class=\"graphic graphic_table graphicRef63858 \" href=\"mobipreview.htm?39/27/40379\">",
"       table 2",
"      </a>",
"      ). Such patients may respond well to therapy directed against the autoimmune hepatitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/36\">",
"       36",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40058?source=see_link\">",
"       \"Treatment of autoimmune hepatitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diagnosing autoimmune hepatitis in patients with underlying nonalcoholic steatohepatitis may be difficult, especially in the presence of a positive ANA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/38\">",
"       38",
"      </a>",
"      ]. In addition to clinical features, the magnitude of fatty infiltration, and the presence of polymorphonuclear leukocytes and central fibrosis in the biopsy may point to steatohepatitis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38105?source=see_link\">",
"       \"Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The term \"lupoid hepatitis\" was formerly used to describe autoimmune hepatitis because of clinical and serologic similarities to systemic lupus erythematosus. As noted above, autoimmune hepatitis may be associated with a number of autoimmune extrahepatic disorders similar to lupus. Autoantibodies may help to distinguish between autoimmune hepatitis and liver disease associated with lupus. Although ANA can be seen in both conditions, ASMA and AMA are rare in lupus; thus, their presence suggests that the patient has autoimmune hepatitis. On the other hand, there is a form of hepatitis that occurs in systemic lupus erythematosus which is distinct from autoimmune hepatitis. Its pathogenesis may be related to the presence of antiribosomal P protein antibodies. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/4/27718?source=see_link\">",
"       \"Antiribosomal P protein antibodies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      It is probable that autoimmune hepatitis also accounts for some cases of cryptogenic chronic hepatitis or cirrhosis in which autoantibodies are absent or will eventually become detectable.",
"     </li>",
"     <li>",
"      Some forms of drug-induced liver disease (DILI) can resemble autoimmune hepatitis histologically, although certain histologic features (eg, portal neutrophils, which are more common in DILI) can help distinguish between the two [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35528/abstract/39\">",
"       39",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/63/29690?source=see_link\">",
"       \"Drugs and the liver: Patterns of drug-induced liver injury\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Iron overload",
"    </span>",
"    &nbsp;&mdash;&nbsp;On occasion, a raised serum ferritin, sometimes accompanied by elevated transferrin saturation, occurs in autoimmune hepatitis or chronic viral hepatitis. Significant iron overload from genetic hemochromatosis can be excluded in this setting by the measurement of hepatic iron concentration and subsequent calculation of the hepatic iron index and HFE mutations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/61/33748?source=see_link\">",
"     \"Hepatic iron concentration and hepatic iron index in the diagnosis of iron overload and hereditary hemochromatosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2288792865\">",
"    <span class=\"h2\">",
"     Wilson disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost exclusively a disease of children, Wilson disease can present as a chronic hepatitis or as fatty liver disease that resembles autoimmune hepatitis. It should be considered in the differential diagnosis of autoimmune hepatitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/48/14088?source=see_link\">",
"     \"Tests used in the diagnosis of Wilson disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/37/13910?source=see_link\">",
"     \"Epidemiology and pathogenesis of Wilson disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/56/25474?source=see_link\">",
"       \"Patient information: Autoimmune hepatitis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autoimmune hepatitis is a chronic hepatitis characterized by immunologic and autoimmunologic features, generally including the presence of circulating autoantibodies and a high serum globulin concentration.",
"     </li>",
"     <li>",
"      Autoimmune hepatitis has a heterogeneous and fluctuating nature, leading to marked variability in its clinical manifestations. Its spectrum ranges from asymptomatic patients to those with considerable and sometimes debilitating symptoms, and even those with acute liver failure. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis is based upon characteristic serologic and histologic findings and exclusion of other forms of chronic liver disease. It can often be strongly suspected based upon clinical and laboratory features, and thus a liver biopsy may not always be necessary in patients with typical findings on noninvasive testing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In adults with compatible clinical or laboratory features, we obtain a serum ANA, SMA, AMA and either a serum protein electrophoresis or quantitative immunoglobulin analysis. In those who are SMA-negative, we obtain SLA and AAA. In children we also obtain anti-LKM1. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is confirmed with positive results on serology and compatible histologic findings after excluding other forms of chronic hepatitis. The scoring system using simplified criteria described above can also be helpful for establishing the diagnosis. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Scoring systems'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/1\">",
"      Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/2\">",
"      Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/3\">",
"      Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51:2193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/4\">",
"      Boberg KM, Aadland E, Jahnsen J, et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/5\">",
"      Werner M, Prytz H, Ohlsson B, et al. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol 2008; 43:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/6\">",
"      Ngu JH, Bechly K, Chapman BA, et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol 2010; 25:1681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/7\">",
"      Primo J, Maroto N, Mart&iacute;nez M, et al. Incidence of adult form of autoimmune hepatitis in Valencia (Spain). Acta Gastroenterol Belg 2009; 72:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/8\">",
"      Muratori P, Granito A, Quarneti C, et al. Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol 2009; 50:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/9\">",
"      Kessler WR, Cummings OW, Eckert G, et al. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004; 2:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/10\">",
"      Bower WA, Johns M, Margolis HS, et al. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007; 102:2459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/11\">",
"      Abe M, Onji M, Kawai-Ninomiya K, et al. Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis. Clin Gastroenterol Hepatol 2007; 5:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/12\">",
"      Stravitz RT, Lefkowitch JH, Fontana RJ, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011; 53:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/13\">",
"      Floreani A, Niro G, Rosa Rizzotto E, et al. Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study. Aliment Pharmacol Ther 2006; 24:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/14\">",
"      Yeoman AD, Al-Chalabi T, Karani JB, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology 2008; 48:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/15\">",
"      Hino-Arinaga T, Ide T, Kuromatsu R, et al. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1. J Gastroenterol 2012; 47:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/16\">",
"      Ngu JH, Gearry RB, Frampton CM, Stedman CA. Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New Zealand. Hepatology 2012; 55:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/17\">",
"      Leung J, Dowling L, Obadan I, et al. Risk of non-melanoma skin cancer in autoimmune hepatitis. Dig Dis Sci 2010; 55:3218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/18\">",
"      Bj&ouml;rnsson E, Talwalkar J, Treeprasertsuk S, et al. Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis. Clin Gastroenterol Hepatol 2011; 9:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/19\">",
"      Hofer H, Oesterreicher C, Wrba F, et al. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol 2006; 59:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/20\">",
"      O'Brien C, Joshi S, Feld JJ, et al. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 2008; 48:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/21\">",
"      Frenzel C, Herkel J, L&uuml;th S, et al. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol 2006; 101:2731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/22\">",
"      Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/23\">",
"      Wies I, Brunner S, Henninger J, et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 2000; 355:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/24\">",
"      Kernebeck T, Lohse AW, Gr&ouml;tzinger J. A bioinformatical approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen/liver pancreas. Hepatology 2001; 34:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/25\">",
"      Herkel J, Heidrich B, Nieraad N, et al. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. Hepatology 2002; 35:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/26\">",
"      Czaja AJ, Morshed SA, Parveen S, Nishioka M. Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis. Hepatology 1997; 26:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/27\">",
"      Bridoux-Henno L, Maggiore G, Johanet C, et al. Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody. Clin Gastroenterol Hepatol 2004; 2:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/28\">",
"      Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/29\">",
"      Yeoman AD, Westbrook RH, Al-Chalabi T, et al. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology 2009; 50:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/30\">",
"      Czaja AJ. Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria. Gastroenterology 2011; 140:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/31\">",
"      Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol 2008; 14:3368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/32\">",
"      Mehendiratta V, Mitroo P, Bombonati A, et al. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol 2009; 7:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/33\">",
"      Dinani AM, Fischer SE, Mosko J, et al. Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis. Clin Gastroenterol Hepatol 2012; 10:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/34\">",
"      Leung PS, Rossaro L, Davis PA, et al. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology 2007; 46:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/35\">",
"      Bernal W, Ma Y, Smith HM, et al. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007; 47:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/36\">",
"      Bellary S, Schiano T, Hartman G, Black M. Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: favorable response to prednisone and azathioprine. Ann Intern Med 1995; 123:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/37\">",
"      Bianchi FB. Autoimmune hepatitis: the lesson of the discovery of hepatitis C virus. J Hepatol 1993; 18:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/38\">",
"      Yatsuji S, Hashimoto E, Kaneda H, et al. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? J Gastroenterol 2005; 40:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35528/abstract/39\">",
"      Suzuki A, Brunt EM, Kleiner DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011; 54:931.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3665 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-84581B2B62-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35528=[""].join("\n");
var outline_f34_44_35528=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1061186526\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Extrahepatic manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Laboratory features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Autoantibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Scoring systems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Acute hepatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Chronic hepatitis C",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Other forms of chronic hepatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Iron overload",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2288792865\">",
"      Wilson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/3665\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/3665|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/4/18510\" title=\"figure 1\">",
"      Polyclonal pattern on SPEP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/3665|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/41/7830\" title=\"picture 1\">",
"      Autoimmune hepatitis Low",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?43/7/44150\" title=\"picture 2\">",
"      Interface hepatitis AASLD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/51/34614\" title=\"picture 3\">",
"      Plasma cell infiltrate AASLD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/48/12040\" title=\"picture 4A\">",
"      Primary biliary cirrhosis I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/16/27911\" title=\"picture 4B\">",
"      Primary biliary cirrhosis II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/61/35796\" title=\"picture 4C\">",
"      Primary sclerosing cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/3665|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/0/8203\" title=\"table 1\">",
"      Classif autoimmune hepatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/27/40379\" title=\"table 2\">",
"      Diagnosis autoimmune hepatitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/4/27718?source=related_link\">",
"      Antiribosomal P protein antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/2/44074?source=related_link\">",
"      Chemotherapy hepatotoxicity and dose modification in patients with liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/32/27140?source=related_link\">",
"      Classification of autoimmune hepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/28/9674?source=related_link\">",
"      Clinical spectrum of antineutrophil cytoplasmic antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/4/35911?source=related_link\">",
"      Definition and treatment of variants of autoimmune hepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/63/29690?source=related_link\">",
"      Drugs and the liver: Patterns of drug-induced liver injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/38/25194?source=related_link\">",
"      Epidemiology and etiologic associations of hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/37/13910?source=related_link\">",
"      Epidemiology and pathogenesis of Wilson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38105?source=related_link\">",
"      Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/4/31812?source=related_link\">",
"      Extrahepatic manifestations of autoimmune hepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/61/33748?source=related_link\">",
"      Hepatic iron concentration and hepatic iron index in the diagnosis of iron overload and hereditary hemochromatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/8/19590?source=related_link\">",
"      Pathogenesis of autoimmune hepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/56/25474?source=related_link\">",
"      Patient information: Autoimmune hepatitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/55/41849?source=related_link\">",
"      Screening for and diagnosis of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42902?source=related_link\">",
"      Serologic markers of autoimmune hepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/48/14088?source=related_link\">",
"      Tests used in the diagnosis of Wilson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40058?source=related_link\">",
"      Treatment of autoimmune hepatitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_44_35529="Overview of complementary and alternative medicine in pediatrics";
var content_f34_44_35529=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of complementary and alternative medicine in pediatrics",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35529/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35529/contributors\">",
"     Kathi J Kemper, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35529/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35529/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35529/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35529/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/44/35529/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many Americans turn to complementary and alternative medical (CAM) therapies for themselves and their children. Pediatric health care providers should have some knowledge regarding CAM because they may be asked to advise patients regarding these therapies or provide referrals to CAM practitioners. Pediatric clinicians should be aware of the CAM therapies their patients are using and know where to turn for additional information when questions arise (",
"    <a class=\"graphic graphic_table graphicRef78642 \" href=\"mobipreview.htm?11/50/12076\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will provide an overview of the use of CAM therapies in pediatrics. The use of CAM therapies for specific disorders, such as autism spectrum disorders, is discussed in the relevant treatment topics. As an example, see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/54/16234?source=see_link\">",
"     Autism spectrum disorders in children and adolescents: Complementary and alternative therapies",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Integrative medicine is relationship-based care that focuses on the whole person; is informed by evidence; and makes use of all appropriate therapeutic approaches, health care professionals, and disciplines to promote optimal health and healing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complementary therapies are a subset of integrative medicine. The list of practices that are considered to be complementary or alternative changes as practices and therapies become part of mainstream medicine over time and in different cultures. Integrative medicine encompasses some common basic values. These values reflect the importance of individual rights and the increasing education levels and access to information that characterize modern society:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recognition of the primary importance of treating the patient as an individual rather than a constellation of symptoms (patient-centered care)",
"     </li>",
"     <li>",
"      Recognition that the family has the primary role in providing care and that the role of the clinician is one of counselor, teacher, and advice giver rather than issuer of orders",
"     </li>",
"     <li>",
"      Recognition that family-clinician relationships are partnerships, as opposed to hierarchies",
"     </li>",
"     <li>",
"      Recognition of the importance of a sustainable healing environment",
"     </li>",
"     <li>",
"      Recognition of the inherent healing ability of the individual",
"     </li>",
"     <li>",
"      Recognition of the importance of prevention and health promotion",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Alternative",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alternative medicine refers to therapies that are not usually taught at American medical schools, are not provided in hospitals, are not reimbursed by third-party payers, and lack evidence of effectiveness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/3\">",
"     3",
"    </a>",
"    ]. Changes in practice and emerging research render this definition problematic:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      More than one-half of American medical schools now offer courses on alternative therapies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/4\">",
"       4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Many therapies that formerly were considered alternative now are offered in pediatric settings, including hospitals (eg, massage for newborn infants, acupuncture for patients with severe pain)",
"     </li>",
"     <li>",
"      Increasing numbers of third-party payers now reimburse families for services once considered alternative",
"     </li>",
"     <li>",
"      New evidence is emerging regarding the safety and effectiveness of a variety of dietary supplements, massage, and other therapies",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Complementary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complementary therapies are used in conjunction with mainstream medical therapies. These therapies do not replace medical regimens for serious medical problems but are offered to support the patient and family. Examples include massage, support groups, guided imagery, biofeedback, and hypnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Folk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Folk medicine refers to therapies that are provided by family or group members as part of a family or cultural tradition. Examples include using \"cold\" foods for \"hot\" illnesses, religious or ritual healing practices (eg, coining or sand painting), and using chicken soup to treat upper respiratory infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Integrative",
"    </span>",
"    &nbsp;&mdash;&nbsp;Integrative medicine refers to the integration of complementary and alternative medicine therapies into mainstream medical practice based upon evidence of safety and effectiveness (",
"    <a class=\"graphic graphic_table graphicRef82394 \" href=\"mobipreview.htm?16/23/16765\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/7\">",
"     7",
"    </a>",
"    ]. As an example, a pediatric clinician may recommend ginger as a treatment for nausea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Holistic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Holistic medicine refers to the care of the whole patient (eg, body, mind, emotions, spirit, and relationships) in the context of his or her values, beliefs, culture, and community. Holistic medicine is closely related to comprehensive care and contextual pediatrics. Examples of holistic medicine include promotion of literacy, screening for depression or alcohol use in family members, and promotion of housecleaning to reduce allergic symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The annual number of outpatient visits to complementary and alternative medicine (CAM) providers is greater than the number of outpatient visits to mainstream clinicians in the United States. In addition, out-of-pocket expenditures for CAM are greater than those spent for hospitalization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The percentage of general pediatric patients using CAM care increased from approximately 11 to 20 percent between 1994 and 1997. The percentage may be greater than 70 percent for children and families who have chronic, recurrent, or fatal conditions (eg, rheumatoid arthritis, cancer), depending upon age, cultural background, and access to services [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/1,12-17\">",
"     1,12-17",
"    </a>",
"    ]. As an example, oncology patients accounted for 63 percent of the consultations to a holistic medicine consultation service in an urban tertiary-care pediatric hospital [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/13/40154?source=see_link\">",
"     \"Complementary and alternative therapies for cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/21/7513?source=see_link\">",
"     \"Complementary and alternative remedies in rheumatic disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chiropractors, acupuncturists, naturopaths, homeopaths, and massage therapists are the professional CAM providers most often used by children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/19\">",
"     19",
"    </a>",
"    ]. The CAM therapies most often sought include prayer and spiritual healing, vitamins, minerals, herbs and other dietary supplements, special diets, massage, and",
"    <span class=\"nowrap\">",
"     mind/body",
"    </span>",
"    techniques, such as relaxation training, hypnosis, and biofeedback [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     RELATIONSHIP BETWEEN CAM AND MAINSTREAM MEDICINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients and families may or may not discuss their use of complementary and alternative medicine (CAM) with their mainstream health care providers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/1,11,20,22\">",
"     1,11,20,22",
"    </a>",
"    ]. However, CAM and mainstream medical therapies may have adverse interactions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Thus, it is important that the pediatric clinician routinely obtain a complete history, including use of CAM therapies and services (",
"    <a class=\"graphic graphic_table graphicRef57149 \" href=\"mobipreview.htm?15/51/16188\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Pediatric clinicians may be concerned that families who use CAM are unsatisfied with mainstream medical care and will abandon effective therapies for unproven alternatives, which has been associated with adverse outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/24\">",
"     24",
"    </a>",
"    ]. However, families who use CAM therapies rarely abandon their mainstream pediatric clinicians, and adverse effects associated with CAM and",
"    <span class=\"nowrap\">",
"     CAM/conventional",
"    </span>",
"    interactions appear to be less frequent than known adverse effects from conventional therapies. CAM typically is used as an adjunct rather than an alternative to mainstream medical care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/18,25,26\">",
"     18,25,26",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a random sample of children admitted to a general pediatric service, the proportion of children who had seen their primary care pediatrician during the acute illness did not differ according to use of complementary treatments [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/25\">",
"       25",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The majority of consultations with a holistic medicine team in a tertiary-care pediatric hospital were for management of symptoms, rather than cure (70 versus 9 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/18\">",
"       18",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Families seek care from providers who respect them as individuals and who offer them time and attention. They also seek information on healthy lifestyle choices, dietary supplements, and environmental therapies over which they may exert some control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/27\">",
"     27",
"    </a>",
"    ]. Thus, they turn to CAM therapists who offer them personal attention, hope, time, and therapies consistent with their values, world view, and culture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27285936\">",
"    <span class=\"h1\">",
"     DISCUSSING CAM THERAPIES WITH PATIENTS AND FAMILIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric clinicians may find it helpful to use a structured approach when discussing therapeutic options, including complementary therapies, with their patients or families (",
"    <a class=\"graphic graphic_table graphicRef57149 \" href=\"mobipreview.htm?15/51/16188\">",
"     table 3",
"    </a>",
"    ). Such an approach permits the provider to obtain a complete history, a better understanding of the values and belief systems of their patients, and a better framework from which to offer advice regarding potential adverse effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The American Academy of Pediatrics has established recommendations for pediatric clinicians who discuss alternative complementary and unproven therapies with their families [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Seek information for yourself and be prepared to share it with families",
"     </li>",
"     <li>",
"      Evaluate the scientific merits of specific therapeutic approaches",
"     </li>",
"     <li>",
"      Identify risks or potential harmful effects",
"     </li>",
"     <li>",
"      Provide families with information on a range of treatment options",
"     </li>",
"     <li>",
"      Educate families to evaluate information about all treatment approaches",
"     </li>",
"     <li>",
"      Avoid dismissal of complementary and alternative medicine (CAM) in ways that communicate a lack of sensitivity or concern for the family's perspective",
"     </li>",
"     <li>",
"      Recognize when the family feels threatened and guard against becoming defensive",
"     </li>",
"     <li>",
"      If the CAM approach is endorsed, offer to assist in monitoring and evaluate the response",
"     </li>",
"     <li>",
"      Actively listen to the family and the child with chronic illness",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27285945\">",
"    <span class=\"h2\">",
"     Medicolegal considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medicolegal considerations are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef50163 \" href=\"mobipreview.htm?36/9/37020\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/31\">",
"     31",
"    </a>",
"    ]. In addition to the standard documentation of the history, physical examination, diagnostic test results, and reports from consultants, the documentation in the medical record should include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The conventional medical therapies that have been discussed, offered, tried, or refused",
"     </li>",
"     <li>",
"      Discussion of the risks and benefits of the recommended CAM treatment",
"     </li>",
"     <li>",
"      That the clinician has determined the extent to which the CAM therapy could interfere with any other recommended or ongoing treatment",
"     </li>",
"     <li>",
"      Appropriate informed consent",
"     </li>",
"     <li>",
"      Treatments and medications (including date, type, dose, and quantity prescribed)",
"     </li>",
"     <li>",
"      Instructions and agreements",
"     </li>",
"     <li>",
"      Periodic reviews",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CAM PROFESSIONALS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number and types of professionals who practice complementary and alternative medicine (CAM) continue to grow (",
"    <a class=\"graphic graphic_table graphicRef64775 \" href=\"mobipreview.htm?12/60/13260\">",
"     table 5",
"    </a>",
"    ). These professionals include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chiropractors",
"     </li>",
"     <li>",
"      Acupuncturists",
"     </li>",
"     <li>",
"      Naturopathic doctors",
"     </li>",
"     <li>",
"      Licensed massage therapists and bodyworkers",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Chiropractors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chiropractors believe that malalignment of the spine is a major source of morbidity. However, spinal manipulation is their principal therapeutic option; chiropractors do not prescribe drugs or perform surgery. Chiropractors are licensed in all 50 states [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/33\">",
"     33",
"    </a>",
"    ]. In 1998, more than 50,000 doctors of chiropractic were in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The chiropractic community is divided into two camps [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/35\">",
"     35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The International Chiropractic Association promotes chiropractic as essential to health promotion and is opposed to mandatory childhood immunizations",
"     </li>",
"     <li>",
"      The American Chiropractic Association tends to focus upon treatment of low back pain and other musculoskeletal disorders and includes exercise, dietary, and nutritional supplement counseling among their therapeutic maneuvers",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Chiropractors are the CAM therapists most often used by adults and children in Canada and the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/3\">",
"     3",
"    </a>",
"    ]. Chiropractors see an average of 120 to 150 patients per week [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/35\">",
"     35",
"    </a>",
"    ]. Initial visits typically last 45 minutes. Patients with acute conditions are scheduled for follow-up two to three times per week. Follow-up visits generally are 15 to 20 minutes long. Nearly one-half of chiropractor fees are covered by third-party payers, including Medicare and most major medical insurance carriers.",
"   </p>",
"   <p>",
"    Children and adolescents account for 10 to 20 percent of chiropractor visits, and most chiropractic schools offer courses in pediatric care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/35\">",
"     35",
"    </a>",
"    ]. When treating children, chiropractors tend to take fewer radiographs, to use lighter force when making adjustments, and to use a device called an activator to make adjustments. They treat children in the parents' laps or use special pediatric tables.",
"   </p>",
"   <p>",
"    Many chiropractors, particularly members of the International Chiropractic Association, promote regular chiropractic care for children as an essential part of pediatric health promotion. However, only about one-third of chiropractors actively recommend childhood immunizations.",
"   </p>",
"   <p>",
"    In addition to health promotion, many chiropractors claim to treat otitis media, asthma, allergies, infantile colic, and enuresis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/36\">",
"     36",
"    </a>",
"    ]. A few randomized trials have evaluated the chiropractic treatment of these acute conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. No well-designed prospective double-blind randomized studies have shown that chiropractic care is as effective as or more effective than mainstream care for these conditions, nor have studies demonstrated the effectiveness of chiropractic care in preventing mild or serious pediatric disorders. On the other hand, significant adverse effects from chiropractic adjustments are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/39-41\">",
"     39-41",
"    </a>",
"    ], and the rate of malpractice claims against chiropractors is much lower than the rate of suits against medical doctors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Acupuncturists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acupuncture, a component of traditional Chinese medicine, is based upon the theory of a vital energy or chi (qi) that circulates through the body in channels called meridians. Disease occurs when the flow of vital energy is disrupted or blocked. Health returns when the flow is restored, balanced, and harmonized. Acupuncture restores the flow of vital energy through stimulation of specific points along the energy meridians.",
"   </p>",
"   <p>",
"    Most American acupuncturists are trained in America. Acupuncturists are licensed in more than 40 states [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/30,33\">",
"     30,33",
"    </a>",
"    ]. However, no national certification or licensure for practicing pediatric acupuncture exists. Approximately 80 percent of licensed acupuncturists also recommend dietary changes, herbs and other supplements, and changes in lifestyle, exercise, rest, and relationships to enhance health. Acupuncture visits rarely are covered by insurance; most patients pay out of pocket for these services unless they are provided by a clinician acupuncturist.",
"   </p>",
"   <p>",
"    Approximately 14,000 practicing acupuncturists are licensed in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/43\">",
"     43",
"    </a>",
"    ]. Acupuncturists typically see 30 to 60 patients per week. Initial visit length is approximately 90 minutes, and follow-up visits last approximately one hour. Acute conditions typically are treated two to three times per week for two to three weeks, after which the visit frequency gradually is reduced until treatment is no longer needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/44\">",
"     44",
"    </a>",
"    ]. Benefits of therapy, when they occur, usually are evident within the first five treatments.",
"   </p>",
"   <p>",
"    Most acupuncturists rarely treat children; less than 10 percent of acupuncturists see three or more children per week. Most acupuncturists who treat children use special techniques, including non-needle methods (eg, heat, magnets, lasers, and vigorous massage or tapping) to stimulate points along the energy meridians. In addition, they may use the Japanese style of acupuncture, which is gentler than the Chinese style.",
"   </p>",
"   <p>",
"    Acupuncture commonly is recommended by clinicians. Many of the major teaching hospitals with a pediatric pain service offer acupuncture to treat chronic pain in children. The National Institutes of Health Consensus Conference on Acupuncture concluded that it was effective in treating several kinds of pain and nausea in adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/45\">",
"     45",
"    </a>",
"    ]. Results in children vary:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one clinical trial, 22 children with migraine headaches were randomly assigned to true acupuncture or placebo acupuncture [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/46\">",
"       46",
"      </a>",
"      ]. Children in the true acupuncture group experienced reduction in the intensity and frequency of headaches, as well as increased activity in the opioidergic system.",
"     </li>",
"     <li>",
"      In another clinical trial, 100 children undergoing tonsillectomy were randomly assigned to acupressure-acupuncture or placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/47\">",
"       47",
"      </a>",
"      ]. Retching",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vomiting occurred with equal frequency in both groups (approximately 60 percent).",
"     </li>",
"     <li>",
"      Acupuncture did not affect postoperative vomiting in 84 children who underwent day surgery and were randomly assigned to transcutaneous stimulation or no stimulation of nausea and analgesia acupuncture points [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A systematic review of 37 studies concluded that needle acupuncture is safe for children when it is performed by appropriately trained practitioners who follow detailed protocols [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/49\">",
"     49",
"    </a>",
"    ]. Among 1422 patients treated with acupuncture, there were 279 adverse events. Most adverse events (91 percent) were mild (eg, pain, bruising, worsening of symptoms). Serious adverse events occurred in 25 patients (9 percent) and included thumb deformity, infection, and nerve impairment, among others. Some of the serious adverse events may have been related to substandard practice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Naturopathic doctors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Naturopathic medicine is based upon the belief that the body has an innate power to heal and that symptoms are the manifestation of the body's attempt to achieve wholeness in the face of internal and external stress. Treatment is focused on restoring the whole person to healthy balance and resilience. Similar to mainstream clinicians, naturopaths help patients to avoid unhealthy habits (eg, smoking, excessive alcohol use, illicit drug use). In addition, naturopathic doctors focus on health promotion, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Healthy diet (low in fat, high in fiber and micronutrients, and free of pesticides, herbicides, and antimicrobials)",
"     </li>",
"     <li>",
"      Exercise",
"     </li>",
"     <li>",
"      Rest",
"     </li>",
"     <li>",
"      Positive mental and emotional state (enhanced by meditation, imagery, and counseling)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Naturopathic therapies include hot and cold baths, steam baths, massage, and dietary supplements such as herbs and vitamins. Some naturopaths incorporate elements of other CAM therapies into their practice (eg, chiropractic, acupuncture, homeopathy, and midwifery).",
"   </p>",
"   <p>",
"    In 1997, the number of naturopathic doctors (NDs) in the US was estimated at 1900, with a threefold growth anticipated by 2012. The four accredited schools of naturopathy in the United States are in Washington, Oregon, Arizona, and Connecticut. Training is four years. Internship and residency are not required. Although a national certifying board (NPLEX) exists, fewer than 15 states license NDs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/30,33\">",
"     30,33",
"    </a>",
"    ]. Third-party coverage of ND services varies by state, but most pediatric care is paid out of pocket by families.",
"   </p>",
"   <p>",
"    Lengths of visits are typically 60 to 90 minutes for an initial visit and 30 to 45 minutes for follow-up. Some families rely upon their ND as the only source of primary care. Children and adolescents account for 20 to 30 percent of NDs' patient loads.",
"   </p>",
"   <p>",
"    Only one-third of NDs report having specific training in pediatrics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/50\">",
"     50",
"    </a>",
"    ]. Little or no training is provided for the recognition of potentially serious pediatric problems (eg, febrile neonates) or standard safety counseling (eg, car seats, smoke detectors, hot water temperature). Only 20 percent of naturopaths actively recommend childhood immunizations, and a small percentage are actively opposed to immunizations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Massage and bodywork",
"    </span>",
"    &nbsp;&mdash;&nbsp;Massage therapists focus on muscles and connective tissues. They do not perform spinal adjustments. Hundreds of types of bodywork and massage exist because almost every cultural group has a tradition of massage therapy. Four major types of bodywork and massage are practiced in the United States:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Swedish massage (long, gliding strokes; kneading; and stroking)",
"     </li>",
"     <li>",
"      Deep tissue massage (eg, Rolfing and Hellerwork)",
"     </li>",
"     <li>",
"      Pressure-point techniques (eg, shiatsu and acupressure)",
"     </li>",
"     <li>",
"      Movement integration (eg, Feldenkrais and Alexander techniques)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The training and licensure for massage therapists vary by location. Massage therapy is regulated by the municipality in some areas and by the state in others. A certifying examination may or may not be required [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/33\">",
"     33",
"    </a>",
"    ]. Massage therapy is licensed within the health care field by some states and within the entertainment field by others. Nurses and physical therapists provide massage therapy for children in some hospital settings.",
"   </p>",
"   <p>",
"    The American Massage Therapy Association is the largest national professional organization of bodyworkers. Membership in this association requires training in an accredited school and hundreds of hours of supervised practice. Most massage schools provide little training in pediatrics, and therapists rarely treat children.",
"   </p>",
"   <p>",
"    A survey of licensed massage therapists in the Boston area revealed that practitioners received 1000 hours of training in massage therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/51\">",
"     51",
"    </a>",
"    ]. Typical visits lasted approximately one hour; the cost of the visit was rarely covered by insurance. Most therapists saw an average of 20 patients per week, with less than one visit per week from a child or adolescent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Substantial and growing evidence indicates that massage helps children and adolescents who suffer from a wide range of conditions. It can ease suffering from anxiety and depression in adolescents who are hospitalized for psychiatric disorders, reduce the severity of asthma in school-age children, and may enhance the growth rate of premature infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/52-61\">",
"     52-61",
"    </a>",
"    ]. Massage therapy also is helpful in relieving pain, improving circulation, loosening tight joints, decreasing levels of stress hormones, enhancing endogenous levels of serotonin, and enhancing an overall sense of relaxation and well-being [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CAM THERAPIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Homeopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Homeopathy is a system of medical treatment invented in the 1800s and currently popular in Europe, Russia, India, and South America [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/17/26903?source=see_link&amp;anchor=H12915827#H12915827\">",
"     \"Homeopathy\", section on 'Basic theory'",
"    </a>",
"    .) It is based upon two principles:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The law of similars",
"     </li>",
"     <li>",
"      The law of dilutions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    According to the law of similars, a remedy that would cause a symptom in a healthy person is used to treat the same symptom in a sick person (\"like cures like\"). As an example, poison ivy might be used to treat a child suffering from eczema. Serious side effects from homeopathic treatments rarely occur. The safety of homeopathy is attributed to its second principle. According to the law of dilutions, the more the remedy is diluted, the more powerful it becomes. Homeopaths believe that dilute remedies contain energy or information that is used by the patient to heal his or her symptoms. In contrast, most mainstream clinicians believe that dilute homeopathic remedies contain no active molecules and that the remedies have a placebo effect that triggers the patient's psycho-neuro-immunologic healing systems.",
"   </p>",
"   <p>",
"    In 1994, homeopathy was the second-most commonly used complementary and alternative medicine (CAM) in children. Nearly two million visits to homeopathic practitioners were made in the US in 1997. An estimated 12,000 homeopaths practice in the United States. Of these, approximately one-half are lay practitioners, 35 percent are chiropractors, 10 percent are clinicians, and the remainder are naturopaths, nurses, and other health professionals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/65\">",
"     65",
"    </a>",
"    ]. Practitioners of homeopathy are licensed in fewer than 10 states [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/30\">",
"     30",
"    </a>",
"    ]. Insurance coverage for homeopathic care varies by state, carrier, and the professional status of the practitioner. Homeopathic services provided by clinicians and chiropractors are covered more often than are services provided by non-clinicians.",
"   </p>",
"   <p>",
"    Homeopathic remedies are available over the counter, through mail-order catalogs, and over the Internet without a prescription. Homeopathic visits are scheduled approximately every four to six weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/50\">",
"     50",
"    </a>",
"    ]. The initial visit usually lasts 90 minutes, and follow-up visits 30 to 45 minutes. Children and adolescents comprise between 20 to 30 percent of the patient load of the typical homeopathic practitioner. In addition to homeopathic remedies, many practitioners of homeopathy discuss and recommend dietary therapies, dietary supplements, and relaxation techniques.",
"   </p>",
"   <p>",
"    Studies evaluating homeopathic remedies in children and adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/17/26903?source=see_link&amp;anchor=H12915949#H12915949\">",
"     \"Homeopathy\", section on 'Clinical evidence'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Bioenergetic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic Touch, Healing Touch, and Reiki are forms of bioenergetic therapy in which healing energy is transferred from the healer to the patient through the healer's hands.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Therapeutic Touch",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic Touch can be performed without touching the patient. The process was developed in the 1970s by a nursing professor and a lay healer and does not require a specific religious faith or belief. The process has five steps:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Having a clear and conscious intent to be helpful and heal",
"     </li>",
"     <li>",
"      Being centered in a peaceful state of mind",
"     </li>",
"     <li>",
"      Using the hands to assess the patient's energy (typically moving the hands 1 to 3 inches away from the body in a slow downward sweep from the head to the toes)",
"     </li>",
"     <li>",
"      Using the hands to help restore the patient's energy to a balanced, harmonious, peaceful state (again, slowly moving the hands a few inches away from the body)",
"     </li>",
"     <li>",
"      Releasing the patient to complete his healing process while the healer returns to his own centered, peaceful state of mind",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Therapeutic Touch is taught in nursing schools across the United States. Nursing practice in many hospitals includes policies and procedures for performing Therapeutic Touch. No national certifying examinations exist for practitioners of Therapeutic Touch. No state currently licenses these practitioners.",
"   </p>",
"   <p>",
"    Studies in adults report that Therapeutic Touch is effective in reducing pain and anxiety and for enhancing sleep and a sense of well-being. Preliminary studies suggest that it may promote wound-healing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/66\">",
"     66",
"    </a>",
"    ]. Few studies have been performed in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. Side effects are rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Healing Touch",
"    </span>",
"    &nbsp;&mdash;&nbsp;Healing Touch grew out of Therapeutic Touch and other energy-based healing traditions. It uses a variety of nontouch or light touch techniques to affect the patient's bioenergy. Practitioners of Healing Touch may be certified through various Healing Touch groups.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Reiki",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reiki is a practice similar to Therapeutic Touch that is based on Japanese tradition. The practice of Reiki relies upon a belief in an invisible energy that may be transmitted from healer to patient through intention; the energy is focused by placing the hands on particular parts of the patient's body. Reiki healers perform long-distance healing in some cases: the patient is visualized, and energy is transmitted through intention rather than direct physical contact.",
"   </p>",
"   <p>",
"    Practitioners of Reiki are trained by a Reiki master through apprenticeship and",
"    <span class=\"nowrap\">",
"     spiritual/energetic",
"    </span>",
"    initiation. It has no national certifying examinations and no state licensure requirements.",
"   </p>",
"   <p>",
"    No studies have evaluated the effectiveness of Reiki in treating children, nor are any side effects reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Guided imagery and biofeedback",
"    </span>",
"    &nbsp;&mdash;&nbsp;Guided imagery, hypnosis, and biofeedback now are part of mainstream medical practice. They are used by clinicians, psychologists, social workers, and other mainstream health professionals. Training in these techniques is available through workshops sponsored by the Society for Behavioral and Developmental Pediatrics, among other places. The techniques have been shown to be useful in promoting optimal performance and in treating pain, behavior problems, and a variety of other pediatric conditions when used as an adjunct to other therapies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/69-74\">",
"     69-74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of biofeedback in the management of specific conditions is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/59/34744?source=see_link&amp;anchor=H14#H14\">",
"     \"Tension-type headache in children\", section on 'Frequent or chronic headaches'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/3/18490?source=see_link&amp;anchor=H25#H25\">",
"     \"Management of migraine headache in children\", section on 'Biofeedback and relaxation techniques'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/36/33354?source=see_link&amp;anchor=H28#H28\">",
"     \"Alternative and experimental agents for the treatment of asthma\", section on 'Biofeedback and functional relaxation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/51/41785?source=see_link&amp;anchor=H15#H15\">",
"     \"Management of bladder dysfunction in children\", section on 'Biofeedback'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Herbs/supplements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Herbs, vitamins, minerals, and other dietary supplements are used with increasing frequency by families of children and adolescents for a variety of indications (",
"    <a class=\"graphic graphic_table graphicRef60567 \" href=\"mobipreview.htm?41/55/42876\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Multivitamins and minerals are promoted as therapies for children who have autism, Down syndrome, and other developmental disabilities. Fish oils, antioxidants, and herbs are marketed for children with attention deficit hyperactivity disorder. Magnesium and a variety of Asian herbs are sought as a natural approach to management of asthma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/75\">",
"     75",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/48/31496?source=see_link\">",
"     \"Chinese herbal medicine for the treatment of allergic diseases\"",
"    </a>",
"    .) Adolescents spend money on dietary supplements to lose weight, build strength, enhance mood, and clear skin blemishes.",
"   </p>",
"   <p>",
"    Pediatric clinicians should advise caution about potential toxicities from herbs and dietary supplements (",
"    <a class=\"graphic graphic_table graphicRef65283 \" href=\"mobipreview.htm?1/39/1660\">",
"     table 7",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/4/20554?source=see_link&amp;anchor=H24#H24\">",
"     \"Overview of herbal medicine and dietary supplements\", section on 'Safety'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/2/25642?source=see_link\">",
"     \"Hepatotoxicity due to herbal medications and dietary supplements\"",
"    </a>",
"    .) Natural products (eg, digitalis, hemlock, tobacco) can have potent physical effects, some of which are obvious after one dose, others of which occur over years of accumulated exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2179801020\">",
"    <span class=\"h2\">",
"     Meditation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meditation is a mind-body therapy that is intended to enhance focus or attention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/77\">",
"     77",
"    </a>",
"    ]. Meditation practices are commonly used to promote health or to relieve stress, anxiety, insomnia, depression, chronic pain, or fatigue. In a 2007 survey, approximately 1 percent of children reported using meditation for health purposes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Major types of meditation practice used for health purposes include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/77\">",
"     77",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Concentration on a word, thought, sensation, or image (eg, transcendental meditation, breathing awareness)",
"     </li>",
"     <li>",
"      Mindfulness (the intention to notice without judgment the experiences that arise in each moment)",
"     </li>",
"     <li>",
"      Movement (eg, yoga, tai chi, qi gong, Sufi dancing)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is some evidence to suggest that one or more of these meditation techniques may be beneficial in reducing blood pressure and improving attention, behavior, and psychological functioning in children and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/79-85\">",
"     79-85",
"    </a>",
"    ]. Although additional studies are necessary to confirm these benefits, meditation practices are unlikely to be harmful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Lifestyle therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lifestyle therapies include special diets, exercise, and environmental manipulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diet is a lifestyle therapy that is used commonly by families who pursue complementary and alternative approaches because diet, particularly for young children, is controlled by the family. Diet typically is discussed by pediatric clinicians as part of routine health supervision visits. However, families also may seek advice regarding diet from other health professionals (eg, nutritionists, naturopathic doctors, chiropractors, and licensed acupuncturists) or lay advisers within their cultural communities.",
"   </p>",
"   <p>",
"    Parents may choose vegetarian, macrobiotic, or other special diets for religious, ethical, or health reasons. They may choose to purchase only organically grown meat and produce. They may wish to have their children avoid possible allergens (eg, wheat, dairy products, strawberries, shellfish, corn, soy, and peanuts). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/4/8266?source=see_link\">",
"     \"Vegetarian diets for children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/9/9369?source=see_link\">",
"     \"Organic foods and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Severely restrictive diets, particularly for infants, may result in failure to thrive, malnutrition, and, occasionally, death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/24\">",
"     24",
"    </a>",
"    ]. Parents may not be aware of the potential nutritional deficiencies of restrictive diets for their children or of the means to address these deficiencies within their dietary framework.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to making dietary recommendations, pediatric clinicians also encourage physical activity as part of routine health supervision. Pediatric clinicians should be aware that certain exercise therapies may be useful in the management of specific conditions. As an example, yoga may be particularly useful for children suffering from asthma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35529/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Environmental",
"    </span>",
"    &nbsp;&mdash;&nbsp;Environmental manipulation has long been used in the mainstream medical care of children. Examples include phototherapy for jaundice, vibration for colic, cold for pruritus, and mattress and pillow covers for children with allergy to dust mites. Environmentally based complementary and alternative therapies include crystals, lights, sounds, magnets, ionizers, aromatherapy, and radionic devices. These therapies are marketed as being safe and effective for children. Although data to evaluate these claims are lacking, most of the therapies appear to be benign.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Integrative medicine is relationship-based care that focuses on the whole person; is informed by evidence; and makes use of all appropriate therapeutic approaches, health care professionals, and disciplines to promote optimal health and healing. Complementary therapies are a subset of integrative medicine. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complementary and alternative medicine (CAM) typically is used as an adjunct rather than an alternative to mainstream medical care. Families may turn to CAM therapists who offer them personal attention, hope, time, and therapies consistent with their values, world view, and culture. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Relationship between cam and mainstream medicine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CAM therapies include acupuncture, massage and other types of bodywork, chiropractic, prayer, homeopathy, bioenergetic therapies (Therapeutic Touch, Healing Touch, Reiki), guided imagery and biofeedback, herbs and supplements, and lifestyle therapies (diet, exercise, and environmental manipulation) (",
"      <a class=\"graphic graphic_table graphicRef82394 \" href=\"mobipreview.htm?16/23/16765\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'CAM professionals'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'CAM therapies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pediatric clinicians may find it helpful to use a structured approach when discussing therapeutic options, including complementary therapies, with their patients or families (",
"      <a class=\"graphic graphic_table graphicRef57149 \" href=\"mobipreview.htm?15/51/16188\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H27285936\">",
"       'Discussing CAM therapies with patients and families'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Medicolegal considerations related to the use of CAM therapies are listed in the table (",
"      <a class=\"graphic graphic_table graphicRef50163 \" href=\"mobipreview.htm?36/9/37020\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H27285945\">",
"       'Medicolegal considerations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/1\">",
"      Kemper KJ, Vohra S, Walls R, et al. American Academy of Pediatrics. The use of complementary and alternative medicine in pediatrics. Pediatrics 2008; 122:1374.",
"     </a>",
"    </li>",
"    <li>",
"     National Center for Complementary and Alternative Medicine. Available at: nccam.nih.gov/health (Accessed on December 20, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/3\">",
"      Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/4\">",
"      Wetzel MS, Eisenberg DM, Kaptchuk TJ. Courses involving complementary and alternative medicine at US medical schools. JAMA 1998; 280:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/5\">",
"      Olness K. Hypnosis and biofeedback with children and adolescents; clinical, research, and educational aspects. Introduction. J Dev Behav Pediatr 1996; 17:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/6\">",
"      Pachter LM. Culture and clinical care. Folk illness beliefs and behaviors and their implications for health care delivery. JAMA 1994; 271:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/7\">",
"      Kemper KJ, Cassileth B, Ferris T. Holistic pediatrics: a research agenda. Pediatrics 1999; 103:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/8\">",
"      Kemper KJ. Seven herbs every pediatrician should know. Contemp Pediatr 1996; 13:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/9\">",
"      Needlman R, Fried LE, Morley DS, et al. Clinic-based intervention to promote literacy. A pilot study. Am J Dis Child 1991; 145:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/10\">",
"      Kemper KJ, Osborn LM, Hansen DF, Pascoe JM. Family psychosocial screening: should we focus on high-risk settings? J Dev Behav Pediatr 1994; 15:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/11\">",
"      Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993; 328:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/12\">",
"      Kelly KM, Jacobson JS, Kennedy DD, et al. Use of unconventional therapies by children with cancer at an urban medical center. J Pediatr Hematol Oncol 2000; 22:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/13\">",
"      Stern RC, Canda ER, Doershuk CF. Use of nonmedical treatment by cystic fibrosis patients. J Adolesc Health 1992; 13:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/14\">",
"      Breuner CC, Barry PJ, Kemper KJ. Alternative medicine use by homeless youth. Arch Pediatr Adolesc Med 1998; 152:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/15\">",
"      Sanders H, Davis MF, Duncan B, et al. Use of complementary and alternative medical therapies among children with special health care needs in southern Arizona. Pediatrics 2003; 111:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/16\">",
"      Vlieger AM, Blink M, Tromp E, Benninga MA. Use of complementary and alternative medicine by pediatric patients with functional and organic gastrointestinal diseases: results from a multicenter survey. Pediatrics 2008; 122:e446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/17\">",
"      Tanase A, Zanni R. The use of complementary and alternative medicine among pediatric cystic fibrosis patients. J Altern Complement Med 2008; 14:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/18\">",
"      Kemper KJ, Wornham WL. Consultations for holistic pediatric services for inpatients and outpatient oncology patients at a children's hospital. Arch Pediatr Adolesc Med 2001; 155:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/19\">",
"      Spigelblatt L. Alternative medicine: A pediatric conundrum. Contemp Pediatr 1997; 14:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/20\">",
"      Sawni-Sikand A, Schubiner H, Thomas RL. Use of complementary/alternative therapies among children in primary care pediatrics. Ambul Pediatr 2002; 2:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/21\">",
"      Wilson KM, Klein JD. Adolescents' use of complementary and alternative medicine. Ambul Pediatr 2002; 2:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/22\">",
"      Yussman SM, Ryan SA, Auinger P, Weitzman M. Visits to complementary and alternative medicine providers by children and adolescents in the United States. Ambul Pediatr 2004; 4:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/23\">",
"      Goldman RD, Rogovik AL, Lai D, Vohra S. Potential interactions of drug-natural health products and natural health products-natural health products among children. J Pediatr 2008; 152:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/24\">",
"      Lim A, Cranswick N, South M. Adverse events associated with the use of complementary and alternative medicine in children. Arch Dis Child 2011; 96:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/25\">",
"      Armishaw J, Grant CC. Use of complementary treatment by those hospitalised with acute illness. Arch Dis Child 1999; 81:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/26\">",
"      Philp JC, Maselli J, Pachter LM, Cabana MD. Complementary and alternative medicine use and adherence with pediatric asthma treatment. Pediatrics 2012; 129:e1148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/27\">",
"      Kaptchuk TJ, Eisenberg DM. The persuasive appeal of alternative medicine. Ann Intern Med 1998; 129:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/28\">",
"      Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998; 279:1548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/29\">",
"      Neuberger J. Primary care: core values. Patients' priorities. BMJ 1998; 317:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/30\">",
"      Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med 1997; 127:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/31\">",
"      Cohen MH, Kemper KJ. Complementary therapies in pediatrics: a legal perspective. Pediatrics 2005; 115:774.",
"     </a>",
"    </li>",
"    <li>",
"     Federation of State Medical Boards. Model guidelines for the use of complemenatary and alternative therapies in medical practice (2002). Available at: www.fsmb.org (Accessed on March 08, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/33\">",
"      Eisenberg DM, Cohen MH, Hrbek A, et al. Credentialing complementary and alternative medical providers. Ann Intern Med 2002; 137:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/34\">",
"      Kaptchuk TJ, Eisenberg DM. Chiropractic: origins, controversies, and contributions. Arch Intern Med 1998; 158:2215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/35\">",
"      Lee AC, Li DH, Kemper KJ. Chiropractic care for children. Arch Pediatr Adolesc Med 2000; 154:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/36\">",
"      Pollentier A, Langworthy JM. The scope of chiropractic practice: a survey of chiropractors in the UK. Clin Chiropractic 2007; 10:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/37\">",
"      Olafsdottir E, Forshei S, Fluge G, Markestad T. Randomised controlled trial of infantile colic treated with chiropractic spinal manipulation. Arch Dis Child 2001; 84:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/38\">",
"      Nielsen NH, Bronfort G, Bendix T, et al. Chronic asthma and chiropractic spinal manipulation: a randomized clinical trial. Clin Exp Allergy 1995; 25:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/39\">",
"      Senstad O, Leboeuf-Yde C, Borchgrevink C. Frequency and characteristics of side effects of spinal manipulative therapy. Spine (Phila Pa 1976) 1997; 22:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/40\">",
"      Shafrir Y, Kaufman BA. Quadriplegia after chiropractic manipulation in an infant with congenital torticollis caused by a spinal cord astrocytoma. J Pediatr 1992; 120:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/41\">",
"      Vohra S, Johnston BC, Cramer K, Humphreys K. Adverse events associated with pediatric spinal manipulation: a systematic review. Pediatrics 2007; 119:e275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/42\">",
"      Studdert DM, Eisenberg DM, Miller FH, et al. Medical malpractice implications of alternative medicine. JAMA 1998; 280:1610.",
"     </a>",
"    </li>",
"    <li>",
"     Mitchell BB. Acupuncture and Oriental Medicine Laws. 2001 ed. National Acupuncture Foundation, Gig Harbor, WA, 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/44\">",
"      Lee AC, Highfield ES, Berde CB, Kemper KJ. Survey of acupuncturists: practice characteristics and pediatric care. West J Med 1999; 171:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/45\">",
"      Acupuncture. NIH Consens Statement 1997; 15:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/46\">",
"      Pintov S, Lahat E, Alstein M, et al. Acupuncture and the opioid system: implications in management of migraine. Pediatr Neurol 1997; 17:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/47\">",
"      Shenkman Z, Holzman RS, Kim C, et al. Acupressure-acupuncture antiemetic prophylaxis in children undergoing tonsillectomy. Anesthesiology 1999; 90:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/48\">",
"      Schwager KL, Baines DB, Meyer RJ. Acupuncture and postoperative vomiting in day-stay paediatric patients. Anaesth Intensive Care 1996; 24:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/49\">",
"      Adams D, Cheng F, Jou H, et al. The safety of pediatric acupuncture: a systematic review. Pediatrics 2011; 128:e1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/50\">",
"      Lee AC, Kemper KJ. Homeopathy and naturopathy: practice characteristics and pediatric care. Arch Pediatr Adolesc Med 2000; 154:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/51\">",
"      Lee AC, Kemper KJ. Practice patterns of massage therapists. J Altern Complement Med 2000; 6:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/52\">",
"      Field T, Morrow C, Valdeon C, et al. Massage reduces anxiety in child and adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry 1992; 31:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/53\">",
"      Field TM, Quintino O, Hernandez-Reif M, Koslovsky G. Adolescents with attention deficit hyperactivity disorder benefit from massage therapy. Adolescence 1998; 33:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/54\">",
"      Field T, Grizzle N, Scafidi F, Schanberg S. Massage and relaxation therapies' effects on depressed adolescent mothers. Adolescence 1996; 31:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/55\">",
"      Field T, Henteleff T, Hernandez-Reif M, et al. Children with asthma have improved pulmonary functions after massage therapy. J Pediatr 1998; 132:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/56\">",
"      Field T. Stimulation of preterm infants. Pediatr Rev 1988; 10:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/57\">",
"      Vickers A, Ohlsson A, Lacy JB, Horsley A. Massage for promoting growth and development of preterm and/or low birth-weight infants. Cochrane Database Syst Rev 2004; :CD000390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/58\">",
"      Beider S, Mahrer NE, Gold JI. Pediatric massage therapy: an overview for clinicians. Pediatr Clin North Am 2007; 54:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/59\">",
"      Tsao JC. Effectiveness of massage therapy for chronic, non-malignant pain: a review. Evid Based Complement Alternat Med 2007; 4:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/60\">",
"      Gonzalez AP, Vasquez-Mendoza G, Garc&iacute;a-Vela A, et al. Weight gain in preterm infants following parent-administered Vimala massage: a randomized controlled trial. Am J Perinatol 2009; 26:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/61\">",
"      Suresh S, Wang S, Porfyris S, et al. Massage therapy in outpatient pediatric chronic pain patients: do they facilitate significant reductions in levels of distress, pain, tension, discomfort, and mood alterations? Paediatr Anaesth 2008; 18:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/62\">",
"      Field T, Hernandez-Reif M, Seligman S, et al. Juvenile rheumatoid arthritis: benefits from massage therapy. J Pediatr Psychol 1997; 22:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/63\">",
"      Field T, Peck M, Krugman S, et al. Burn injuries benefit from massage therapy. J Burn Care Rehabil 1998; 19:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/64\">",
"      Berman BM, Singh BK, Lao L, et al. Physicians' attitudes toward complementary or alternative medicine: a regional survey. J Am Board Fam Pract 1995; 8:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/65\">",
"      Ullman D. Homeopathy and managed care: manageable or unmanageable. J Altern Complement Med 1999; 5:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/66\">",
"      Turner JG, Clark AJ, Gauthier DK, Williams M. The effect of therapeutic touch on pain and anxiety in burn patients. J Adv Nurs 1998; 28:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/67\">",
"      Hughes PP, Meize-Grochowski R, Harris CN. Therapeutic touch with adolescent psychiatric patients. J Holist Nurs 1996; 14:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/68\">",
"      Kemper KJ, Fletcher NB, Hamilton CA, McLean TW. Impact of healing touch on pediatric oncology outpatients: pilot study. J Soc Integr Oncol 2009; 7:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/69\">",
"      Bussone G, Grazzi L, D'Amico D, et al. Biofeedback-assisted relaxation training for young adolescents with tension-type headache: a controlled study. Cephalalgia 1998; 18:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/70\">",
"      Fentress DW, Masek BJ, Mehegan JE, Benson H. Biofeedback and relaxation-response training in the treatment of pediatric migraine. Dev Med Child Neurol 1986; 28:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/71\">",
"      Anbar RD. Self-hypnosis for management of chronic dyspnea in pediatric patients. Pediatrics 2001; 107:E21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/72\">",
"      Lambert SA. The effects of hypnosis/guided imagery on the postoperative course of children. J Dev Behav Pediatr 1996; 17:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/73\">",
"      Kline WH, Turnbull A, Labruna VE, et al. Enhancing pain management in the PICU by teaching guided mental imagery: a quality-improvement project. J Pediatr Psychol 2010; 35:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/74\">",
"      Weigensberg MJ, Lane CJ, Winners O, et al. Acute effects of stress-reduction Interactive Guided Imagery(SM) on salivary cortisol in overweight Latino adolescents. J Altern Complement Med 2009; 15:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/75\">",
"      Kemper K, Lester M. Alternative asthma therapies: An evidence based review. Contemp Pediatr 1999; 16:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/76\">",
"      Gardiner P, Phillips R, Shaughnessy AF. Herbal and dietary supplement--drug interactions in patients with chronic illnesses. Am Fam Physician 2008; 77:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/77\">",
"      Sibinga EM, Kemper KJ. Complementary, holistic, and integrative medicine: meditation practices for pediatric health. Pediatr Rev 2010; 31:e91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/78\">",
"      Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/79\">",
"      Barnes VA, Treiber FA, Davis H. Impact of Transcendental Meditation on cardiovascular function at rest and during acute stress in adolescents with high normal blood pressure. J Psychosom Res 2001; 51:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/80\">",
"      Barnes VA, Davis HC, Murzynowski JB, Treiber FA. Impact of meditation on resting and ambulatory blood pressure and heart rate in youth. Psychosom Med 2004; 66:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/81\">",
"      Biegel GM, Brown KW, Shapiro SL, Schubert CM. Mindfulness-based stress reduction for the treatment of adolescent psychiatric outpatients: A randomized clinical trial. J Consult Clin Psychol 2009; 77:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/82\">",
"      Wall RB. Tai Chi and mindfulness-based stress reduction in a Boston Public Middle School. J Pediatr Health Care 2005; 19:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/83\">",
"      Birdee GS, Yeh GY, Wayne PM, et al. Clinical applications of yoga for the pediatric population: a systematic review. Acad Pediatr 2009; 9:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/84\">",
"      Carei TR, Fyfe-Johnson AL, Breuner CC, Brown MA. Randomized controlled clinical trial of yoga in the treatment of eating disorders. J Adolesc Health 2010; 46:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35529/abstract/85\">",
"      Gregoski MJ, Barnes VA, Tingen MS, et al. Breathing awareness meditation and LifeSkills Training programs influence upon ambulatory blood pressure and sodium excretion among African American adolescents. J Adolesc Health 2011; 48:59.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2851 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-16712FB15A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35529=[""].join("\n");
var outline_f34_44_35529=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Alternative",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Complementary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Folk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Integrative",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Holistic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      RELATIONSHIP BETWEEN CAM AND MAINSTREAM MEDICINE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27285936\">",
"      DISCUSSING CAM THERAPIES WITH PATIENTS AND FAMILIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27285945\">",
"      Medicolegal considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CAM PROFESSIONALS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Chiropractors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Acupuncturists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Naturopathic doctors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Massage and bodywork",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CAM THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Homeopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Bioenergetic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Therapeutic Touch",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Healing Touch",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Reiki",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Guided imagery and biofeedback",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Herbs/supplements",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2179801020\">",
"      Meditation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Lifestyle therapies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Diet",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Exercise",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Environmental",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/2851\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2851|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/50/12076\" title=\"table 1\">",
"      CAM resources",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/23/16765\" title=\"table 2\">",
"      Integrative approach CAM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/51/16188\" title=\"table 3\">",
"      CAM discussion points",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/9/37020\" title=\"table 4\">",
"      Medicolegal considerations CAM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/60/13260\" title=\"table 5\">",
"      CAM professionals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/55/42876\" title=\"table 6\">",
"      Common herbal therapies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/39/1660\" title=\"table 7\">",
"      Potential toxicity herbs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/36/33354?source=related_link\">",
"      Alternative and experimental agents for the treatment of asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/54/16234?source=related_link\">",
"      Autism spectrum disorders in children and adolescents: Complementary and alternative therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/48/31496?source=related_link\">",
"      Chinese herbal medicine for the treatment of allergic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/21/7513?source=related_link\">",
"      Complementary and alternative remedies in rheumatic disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/13/40154?source=related_link\">",
"      Complementary and alternative therapies for cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/2/25642?source=related_link\">",
"      Hepatotoxicity due to herbal medications and dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/17/26903?source=related_link\">",
"      Homeopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/51/41785?source=related_link\">",
"      Management of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/3/18490?source=related_link\">",
"      Management of migraine headache in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/9/9369?source=related_link\">",
"      Organic foods and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/4/20554?source=related_link\">",
"      Overview of herbal medicine and dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/59/34744?source=related_link\">",
"      Tension-type headache in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/4/8266?source=related_link\">",
"      Vegetarian diets for children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_44_35530="The approach to hematopoietic cell transplantation survivorship";
var content_f34_44_35530=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   The approach to hematopoietic cell transplantation survivorship",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35530/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35530/contributors\">",
"     Corey Cutler, MD, MPH, FRCP(C)",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35530/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35530/contributors\">",
"     Kenneth D Miller, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35530/contributors\">",
"     Larissa Nekhlyudov, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/44/35530/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/44/35530/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/44/35530/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H94492335\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematopoietic cell transplantation (HCT) refers to the administration of hematopoietic progenitor cells from any source (eg, bone marrow, peripheral blood, umbilical cord blood) or donor (eg, allogeneic, autologous) to reconstitute the bone marrow. Autologous HCT uses hematopoietic progenitor cells derived from the individual with the disorder. In contrast, allogeneic HCT uses hematopoietic progenitor cells collected from someone other than the individual with the disorder. Autologous and allogeneic HCT are used increasingly to treat a variety of hematologic neoplasms, nonmalignant marrow disorders, and inborn errors of metabolism. Worldwide there are more than 40,000 HCTs performed each year.",
"   </p>",
"   <p>",
"    Coupled with the increased volume of HCT has been a steady improvement in allogeneic transplant outcomes, related largely to refinement in HLA-matching, improved supportive care, and advances in infectious disease therapy. As a result, there are a growing number of long-term survivors of HCT, and the transplant community has recognized the importance of providing specialized care to these individuals. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29306?source=see_link&amp;anchor=H599725#H599725\">",
"     \"Supportive care after hematopoietic cell transplantation\", section on 'Estimating mortality risk'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The quality of life among patients who have undergone autologous HCT is generally excellent. Similarly, the majority of long-term survivors of allogeneic HCT are employed and in reasonably good health, with acceptable objective and subjective function. However, the HCT process exposes these patients to highly toxic therapy and puts them at risk for several long-term complications not routinely seen after conventional doses of chemotherapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiotherapy. In addition, allogeneic transplant recipients are subject to the long-term consequences of chronic graft-versus-host disease (GVHD), which may require specialized care for many years, even when quiescent or resolved. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/59/25529?source=see_link\">",
"     \"Quality of life following hematopoietic cell transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23962?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic review will provide an overview to the care of the HCT survivor, focusing on issues that require attention at approximately one year from HCT onwards. Specific care of the early complications of transplantation, the clinical care of acute and chronic GVHD, and the long-term disease-specific follow-up are discussed elsewhere as is a more in depth discussion of secondary malignancies after HCT. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29306?source=see_link\">",
"     \"Supportive care after hematopoietic cell transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/54/34664?source=see_link\">",
"     \"Hematopoietic support after hematopoietic cell transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10425?source=see_link\">",
"     \"Prevention and treatment of acute graft-versus-host disease: Recommendations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/35/35385?source=see_link\">",
"     \"Treatment of chronic graft-versus-host disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/39/28280?source=see_link\">",
"     \"Malignancy after hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H83240218\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematopoietic cell transplantation (HCT) is a general term for a variety of procedures in which the patient is treated with chemotherapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiation therapy (ie, the &ldquo;preparative regimen&rdquo;) followed by the infusion of hematopoietic progenitor cells. HCT can be broadly divided into subtypes based upon the hematopoietic cell donor, the source of hematopoietic progenitor cells, and the preparative regimen. Each of these factors influences efficacy and the short and long-term toxicities associated with the procedure.",
"   </p>",
"   <p>",
"    The hematopoietic cell donor may be (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/38/26218?source=see_link\">",
"     \"Donor selection for hematopoietic cell transplantation\"",
"    </a>",
"    ): &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Autologous",
"      </strong>",
"      &mdash; Autologous HCT refers to when hematopoietic progenitor cells are collected from the patient prior to the administration of high dose chemotherapy designed to target an underlying malignancy. The reinfusion of the patient&rsquo;s hematopoietic progenitor cells rescues the patient from long-lasting, usually irreversible, profound pancytopenia. Autologous HCT is usually not associated with graft-versus-host disease (GVHD). &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Syngeneic",
"      </strong>",
"      &mdash; Syngeneic HCT refers to the use of hematopoietic progenitor cells that come from an identical twin. Syngeneic donors offer the advantage of providing a graft that is free of tumor cells and is only associated with a minimal risk of GVHD.",
"     </li>",
"     <li>",
"      <strong>",
"       Allogeneic",
"      </strong>",
"      &mdash; Allogeneic HCT refers to the use of hematopoietic progenitor cells collected from a relative (which can be HLA identical, haploidentical, or mismatched) or an unrelated donor (volunteer or umbilical cord donor). These grafts are free of tumor, but may be associated with potentially detrimental GVHD as well as a potentially beneficial graft-versus-tumor effect. The period of pancytopenia immediately following HCT is longer than for autologous HCT and immunosuppressive agents are commonly used for prophylaxis against and treatment of GVHD. The combination of these two factors and others results in a higher rate of complications than after autologous or syngeneic HCT, especially infectious complications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The source of the hematopoietic progenitor cells may be (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/49/38682?source=see_link\">",
"     \"Sources of hematopoietic stem cells\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Peripheral blood",
"      </strong>",
"      &mdash; Peripheral blood progenitor cells can be collected using hematopoietic growth factors.",
"     </li>",
"     <li>",
"      <strong>",
"       Umbilical cord blood",
"      </strong>",
"      &mdash; Unrelated umbilical cord blood can be administered in single or double units and is associated with a lower risk of graft-versus-host disease than anticipated for allogeneic peripheral blood progenitor cell transplantation.",
"     </li>",
"     <li>",
"      <strong>",
"       Bone marrow",
"      </strong>",
"      &mdash; Bone marrow progenitor cells are harvested directly from the pelvic bones. Bone marrow recovery is slower than with peripheral blood progenitor cells, but the rate of chronic GVHD may be lower with bone marrow transplantation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Preparative regimens for HCT have been termed myeloablative, reduced intensity, and nonmyeloablative. While full agreement has not been achieved, generally accepted definitions of these three types of regimens are as follows (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/34/25130?source=see_link\">",
"     \"Preparative regimens for hematopoietic cell transplantation\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Myeloablative regimens",
"      </strong>",
"      &mdash; A myeloablative regimen consists of a single agent or combination of agents, typically chemotherapy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      radiation therapy, expected to destroy the hematopoietic cells in the bone marrow and results in profound pancytopenia that is long-lasting, usually irreversible, and in most instances fatal, unless hematopoiesis is restored by infusion of hematopoietic stem cells. Examples include total body irradiation &ge;5 Gy in a single dose or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/10/10408?source=see_link\">",
"       busulfan",
"      </a>",
"      &gt;8",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      orally.",
"     </li>",
"     <li>",
"      <strong>",
"       Nonmyeloablative regimens",
"      </strong>",
"      &mdash; A nonmyeloablative regimen is one that will cause minimal cytopenia (but significant lymphopenia) by itself and does not require stem cell support. Examples include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9545?source=see_link\">",
"       fludarabine",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      with or without antithymocyte globulin or total body irradiation &le;2 Gy with or without a purine analog. Following the administration of allogeneic hematopoietic stem cells the engrafting donor T-cells will eventually eliminate host hematopoietic cells, allowing the establishment of donor hematopoiesis.",
"     </li>",
"     <li>",
"      <strong>",
"       Reduced intensity regimens",
"      </strong>",
"      &mdash; Reduced intensity regimens are an intermediate category of preparative regimens that do not fit the definition of myeloablative or nonmyeloablative. Such regimens cause cytopenias, which may be prolonged and result in significant morbidity and mortality, and require hematopoietic stem cell support. Regimens generally considered as reduced intensity include &le;9",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      of oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/10/10408?source=see_link\">",
"       busulfan",
"      </a>",
"      or &le;140",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/54/22376?source=see_link\">",
"       melphalan",
"      </a>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While it was initially postulated that long-term transplant-related toxicities would be less after reduced intensity or nonmyeloablative HCT, the long-term follow-up of most patients undergoing these types of HCT is short and preliminary data suggest that long-term complications may be equivalent regardless of conditioning intensity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H622013943\">",
"    <span class=\"h1\">",
"     OVERVIEW OF CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;HCT survivors are at risk of developing therapy-related complications that may present years after treatment (eg, second malignancies, cardiac disease, radiation-induced hypothyroidism). These complications have surfaced as significant causes of increased mortality, and screening for some of these entities is advised in the hope that early detection may lead to better management. As such, HCT survivors should be assessed periodically to monitor for potential complications.",
"   </p>",
"   <p>",
"    Comprehensive joint consensus guidelines from the European Group for Blood and Marrow Transplantation (EBMT), the Center for International Blood and Marrow Transplant Research (CIBMTR), and the American Society of Blood and Marrow Transplantation (ASBMT) were published in 2006, and updated in 2012, and recommend appropriate screening studies to monitor for the long-term complications of HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Our approach is in general agreement with these guidelines (",
"    <a class=\"graphic graphic_table graphicRef59471 \" href=\"mobipreview.htm?39/41/40604\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H622014148\">",
"    <span class=\"h2\">",
"     Individualized care plan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individualization of care plans is crucial for hematopoietic cell transplantation (HCT) survivors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/3\">",
"     3",
"    </a>",
"    ]. Preventive health measures should be emphasized, since it is known that both cancer and HCT survivors do not have better patterns of preventive health behavior when compared with non-cancer patients despite having higher levels of engagement with health care providers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In addition, when compared with their siblings, long-term HCT survivors are more likely to have trouble maintaining health insurance coverage and are more likely to have chronic medical conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Long-term care provided through a multispecialty clinic that can cater to the individual needs of the long-term HCT patient is optimal. Unfortunately, this multispecialty clinic model may not be practical in centers with low HCT patient volume. In the absence of a multispecialty clinic, centers should develop a plan for screening patients for the long-term complications of transplantation, based upon the individual patient history, considering factors such as (see",
"    <a class=\"local\" href=\"#H83240218\">",
"     'Terminology'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pretransplant chemotherapy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      radiotherapy for malignancy",
"     </li>",
"     <li>",
"      Donor type (autologous versus allogeneic)",
"     </li>",
"     <li>",
"      Transplant conditioning therapy (preparative regimen)",
"     </li>",
"     <li>",
"      Early complications of transplantation (acute graft-versus-host disease, infections)",
"     </li>",
"     <li>",
"      Age and gender of the patient",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While the emergence of chronic health conditions cannot be altered with screening practices alone, it is hoped that the severity and consequences of the resulting conditions can be altered. This issue remains relevant in the long term, since over 10 percent of the two-year survivors in one report subsequently died of non-relapse related causes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/6\">",
"     6",
"    </a>",
"    ]. Despite this, it is estimated that five-year survivors of HCT may have long-term survival that approaches survival rates in age-matched populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/8-10\">",
"     8-10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172320119\">",
"    <span class=\"h3\">",
"     Autologous HCT survivor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long term toxicities of autologous HCT include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Treatment-related",
"      <span class=\"nowrap\">",
"       myelodysplasia/secondary",
"      </span>",
"      leukemia",
"     </li>",
"     <li>",
"      Secondary solid tumors",
"     </li>",
"     <li>",
"      Cardiac disease",
"     </li>",
"     <li>",
"      Pulmonary toxicity",
"     </li>",
"     <li>",
"      Infection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A retrospective analysis of 309 patients who underwent autologous HCT for relapsed or refractory diffuse large B-cell lymphoma reported that non-relapse mortality surpassed relapse as the main cause of death beginning approximately eight years post-HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/11\">",
"     11",
"    </a>",
"    ]. The most common causes of non-relapse mortality in these patients were respiratory failure (31 percent), infection (13 percent), cardiac toxicity (15 percent), and secondary malignancy (15 percent). While the overall mortality rate became closer to that of the general population as the length of time from HCT increased, it did not return to normal even after 15 years of follow-up. The most common cause of non-relapse mortality in the first two years was respiratory failure and infection. After two years, secondary malignancies accounted for the most common cause of non-relapse mortality.",
"   </p>",
"   <p>",
"    The importance of nonmalignant late toxicity was demonstrated in another large retrospective analysis that reported a cumulative incidence of nonmalignant late effects of 45 percent at five years after autologous HCT with 2.5 percent of patients having three or more late effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172320127\">",
"    <span class=\"h3\">",
"     Allogeneic HCT survivor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common long term toxicities of allogeneic HCT include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic graft-versus-host disease (GVHD)",
"     </li>",
"     <li>",
"      Infections",
"     </li>",
"     <li>",
"      Treatment-related",
"      <span class=\"nowrap\">",
"       myelodysplasia/secondary",
"      </span>",
"      leukemia",
"     </li>",
"     <li>",
"      Secondary solid tumors",
"     </li>",
"     <li>",
"      Cardiac disease",
"     </li>",
"     <li>",
"      Pulmonary toxicity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A cohort analysis of 1479 patients who had survived at least two years after allogeneic HCT with a median follow-up of 9.5 years reported that relapse of the primary disease was the most common cause of death, accounting for 29 percent of all deaths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/7\">",
"     7",
"    </a>",
"    ]. The majority of deaths due to relapse occurred between the second and fifth year of follow-up (67 percent). The most common causes of non-relapse mortality were chronic GVHD (22 percent), late infection in the absence of chronic GVHD (11 percent), subsequent malignancy (7 percent), pulmonary complications (5 percent), cardiac toxicity (2 percent), and other treatment-related events (8 percent). Non-transplant related causes of death were implicated in 3 percent.",
"   </p>",
"   <p>",
"    Multiple nonmalignant late toxicities are common in the allogeneic HCT survivor. As an example, another large retrospective analysis reported a cumulative incidence of nonmalignant late effects of 79 percent at five years after allogeneic HCT, with 26 percent of patients having three or more late effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/12\">",
"     12",
"    </a>",
"    ]. HCT survivors with at least three late effects were more likely to have limitations in their physical and social functioning. &nbsp;",
"   </p>",
"   <p>",
"    Importantly, the care of a patient after allogeneic HCT differs depending upon whether the patient has evidence of chronic GVHD. Chronic GVHD and its treatment place the patient at increased risk of infectious, ocular, dermatologic, hepatic, gastrointestinal, and pulmonary complications. Such complications can still occur, but are less common in patients without GVHD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23962?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H94492358\">",
"     'Common medical problems following transplant'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28851851\">",
"    <span class=\"h3\">",
"     Pediatric transplant survivor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several cohort studies have documented that, when compared with patients who underwent HCT as an adults, survivors of pediatric HCT have similar rates of long-term pulmonary complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/13\">",
"     13",
"    </a>",
"    ], hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/14\">",
"     14",
"    </a>",
"    ], neurosensory defects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/15\">",
"     15",
"    </a>",
"    ], and diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/16\">",
"     16",
"    </a>",
"    ]. There are however, unique aspects of transplant survivorship in pediatric patients that deserve attention at specialized transplant centers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/17,18\">",
"     17,18",
"    </a>",
"    ] such as physical and neuropsychological growth and development and the psychological effects of prolonged illness in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/7/7286?source=see_link\">",
"     \"Endocrine surveillance in childhood cancer survivors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/14/7401?source=see_link\">",
"     \"Pubertal development and gonadal function in survivors of childhood cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492358\">",
"    <span class=\"h1\">",
"     COMMON MEDICAL PROBLEMS FOLLOWING TRANSPLANT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492366\">",
"    <span class=\"h2\">",
"     Cardiovascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Survivors of hematopoietic cell transplantation (HCT) have a higher incidence of cardiovascular disease when compared with their non-transplant siblings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/6\">",
"     6",
"    </a>",
"    ]. Studies have estimated the prevalence of long-term cardiovascular complications of transplantation to be approximately 5 percent at five years and 9 percent at 15 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. While it has been postulated that cardiac outcomes would be better after reduced intensity or nonmyeloablative HCT, preliminary data suggest that long-term cardiovascular health is equivalent regardless of conditioning intensity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rate of cardiovascular death in patients who survived at least two years following HCT at one institution was greater (adjusted incidence rate difference 3.6 per 1000 person years, 95% CI 1.7-5.5) than in a matched non-transplant population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/26\">",
"     26",
"    </a>",
"    ]. In this study, the incidence of ischemic heart disease, cardiomyopathy, heart failure, stroke, rhythm disturbance dyslipidemia, diabetes, and renal disease was also greater in transplant survivors and was not affected by whether the graft was allogeneic or autologous; hypertension was more common in allogeneic graft recipients. &nbsp;",
"   </p>",
"   <p>",
"    Several factors contribute to the increased rate of cardiovascular disease in HCT survivors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Long-term use of calcineurin inhibitors used for immunosuppression (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      )",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      corticosteroids after allogeneic HCT are associated with hypertension [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/22\">",
"       22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=see_link&amp;anchor=H3#H3\">",
"       \"Cyclosporine and tacrolimus nephrotoxicity\", section on 'Chronic calcineurin inhibitor nephrotoxicity'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chronic graft-versus-host disease (GVHD) of the liver and drugs used to treat GVHD (ie, calcineurin inhibitors) after allogeneic HCT may contribute to or worsen hyperlipidemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chemotherapy agents (eg, anthracyclines, high dose",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      ) used before or during HCT can lead to delayed nonischemic heart failure after HCT. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/46/41706?source=see_link\">",
"       \"Cardiotoxicity of anthracycline-like chemotherapy agents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/12/40138?source=see_link\">",
"       \"Cardiotoxicity of nonanthracycline cancer chemotherapy agents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chest radiation prior to HCT has been associated with accelerated atherosclerosis and other cardiotoxicity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/28\">",
"       28",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/21/34137?source=see_link\">",
"       \"Cardiotoxicity of radiation therapy for malignancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diabetes, the metabolic syndrome, and renal dysfunction are more common after HCT than in the general population and are associated with an increased incidence of cardiovascular events, such as myocardial infarction, cerebrovascular disease, and heart failure. (See",
"      <a class=\"local\" href=\"#H94492397\">",
"       'Diabetes/metabolic syndrome'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H94492382\">",
"       'Renal dysfunction'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    HCT survivors are at increased risk for developing known cardiac risk factors. A single-center retrospective study of 1885 HCT survivors followed for a median of 5.9 years reported a ten-year cumulative incidence of new onset hypertension, diabetes, and dyslipidemia in 22, 10, and 31 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/29\">",
"     29",
"    </a>",
"    ]. When compared with autologous HCT, allogeneic HCT was associated with the earlier development of these risk factors and an increased likelihood of developing multiple risk factors. Other factors associated with an increased incidence of cardiac risk factors were grade II-IV acute GVHD and the use of total body irradiation in the preparative regimen.",
"   </p>",
"   <p>",
"    Screening and counseling techniques similar to those used for other at risk populations have been applied to HCT survivors with the goal of decreasing mortality from cardiovascular disease after transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/28\">",
"     28",
"    </a>",
"    ]. Cardiac risk factors should be minimized (eg, smoking, obesity, hyperlipidemia, hypertension). Routine post-HCT care should incorporate regular measurement and control of blood pressure, nutritional counseling and obesity control, counseling for smoking cessation, and control of diabetes. Some transplant centers perform annual electrocardiography to screen for asymptomatic coronary disease and refer those with several cardiac risk factors for echocardiography or exercise stress testing.",
"   </p>",
"   <p>",
"    While most cases of heart failure (HF) following HCT occur within the first four years, HF may present more than eight years after HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/30\">",
"     30",
"    </a>",
"    ]. Risk factors for the development of HF in long-term survivors of HCT include a history of anthracycline exposure and the presence of comorbidities such as hypertension, renal insufficiency, and chronic lung disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/30\">",
"     30",
"    </a>",
"    ]. Risk does not appear to be related to specific conditioning (preparative) regimens. The risk of anthracycline-related cardiomyopathy increases with the cumulative dose and time from exposure. For patients who were exposed to anthracyclines during childhood, periodic assessment of left ventricular ejection fraction is recommended by the Children&rsquo;s Oncology Group and the Children&rsquo;s Cancer Study Group (",
"    <a class=\"graphic graphic_algorithm graphicRef58765 \" href=\"mobipreview.htm?10/27/10687\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/19,31-33\">",
"     19,31-33",
"    </a>",
"    ]. While there are no corresponding guidelines for the posttreatment monitoring of adults, clinicians should have a high degree of suspicion for the development of heart failure among adults who have been exposed to anthracyclines. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/46/41706?source=see_link\">",
"     \"Cardiotoxicity of anthracycline-like chemotherapy agents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/12/40138?source=see_link\">",
"     \"Cardiotoxicity of nonanthracycline cancer chemotherapy agents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492374\">",
"    <span class=\"h2\">",
"     Respiratory disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic respiratory failure can occur following autologous or allogeneic HCT. Respiratory failure is more common following allogeneic HCT than following autologous HCT and accounts for approximately five percent of non-relapse late mortality after allogeneic HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/7\">",
"     7",
"    </a>",
"    ]. Respiratory failure is the most common cause of non-relapse late mortality following autologous HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/11\">",
"     11",
"    </a>",
"    ]. Potential causes of chronically impaired lung function after HCT include lung injury from total body irradiation, chemotherapy (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    ), infection and inflammatory pneumonitides. When compared with myeloablative regimens, reduced intensity conditioning regimens are associated with similar infectious and non-infectious pneumonitis risks; however, the damage from chemotherapy and radiation therapy are generally less severe. Bronchiolitis obliterans is often considered a pulmonary manifestation of chronic GVHD and is noted uniquely after allogeneic HCT. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/10/40106?source=see_link\">",
"     \"Pulmonary complications after allogeneic hematopoietic cell transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23962?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease\", section on 'Lung'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/41/17050?source=see_link\">",
"     \"Pulmonary toxicity associated with antineoplastic therapy: Cytotoxic agents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/49/29466?source=see_link\">",
"     \"Pulmonary toxicity associated with antineoplastic therapy: Molecularly targeted agents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/33/24090?source=see_link\">",
"     \"Radiation-induced lung injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Smoking cessation counseling should be provided to all patients who smoke. Pre-transplant pulmonary function testing is performed routinely and is an important predictor of lung impairment and mortality after autologous and allogeneic HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/34\">",
"     34",
"    </a>",
"    ]. Post-transplant pulmonary function testing is dependent upon the type of HCT and the clinical circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Autologous HCT",
"      </strong>",
"      &mdash; For patients who have undergone autologous HCT, post-HCT pulmonary function tests are generally reserved for patients found to have abnormalities on pre-transplant testing or exposure to radiation or other lung toxic agents (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"       bleomycin",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Allogeneic HCT",
"      </strong>",
"      &mdash; Early post-transplant pulmonary function testing, performed two to four months after HCT, is an important predictor of long-term lung impairment and mortality after allogeneic HCT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/35\">",
"       35",
"      </a>",
"      ]. As such, a set of pulmonary function tests should be obtained two to four months after allogeneic HCT to establish a new baseline and again at one year. Residual airflow obstruction and diminished oxygen diffusion capacity may be markers of ongoing inflammatory lung processes. Patients with abnormal findings on post-HCT pulmonary function testing should be considered for annual pulmonary function testing. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4952?source=see_link\">",
"       \"Overview of pulmonary function testing in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional chest imaging (ie, chest radiographs, computed tomography of the chest) is reserved for patients with pulmonary symptoms. Care should be taken to limit the number of imaging studies in this population, particularly in younger individuals, given concerns about radiation exposure and the risk for second malignancies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21785?source=see_link\">",
"     \"Radiation-related risks of imaging studies\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    An aggressive, invasive diagnostic approach is usually justified early in the evaluation of pulmonary problems after HCT. Opportunistic infections are common and specific treatments are available, but there are no sensitive noninvasive methods to diagnose opportunistic infections, and chest radiographs may be completely normal early in the disease. Patients with dyspnea and normal chest radiographs should undergo full pulmonary function testing with arterial blood gas analysis. Computed tomography (CT) of the chest is more sensitive than the plain chest radiograph and can be used as a guide to further invasive diagnostic procedures. Documentation of a restrictive pattern on pulmonary function testing should prompt a chest CT scan to look for subtle interstitial disease. Among patients with respiratory symptoms, echocardiography should be performed in patients with normal pulmonary function tests and a normal chest CT to look for cardiac dysfunction or evidence of pulmonary hypertension. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/10/40106?source=see_link\">",
"     \"Pulmonary complications after allogeneic hematopoietic cell transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/25/14745?source=see_link\">",
"     \"Pulmonary complications after autologous hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H622014608\">",
"    <span class=\"h2\">",
"     Liver disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term survivors of HCT are at risk of developing liver dysfunction related to chronic graft-versus-host disease (GVHD), viral hepatitis, medications used to treat other conditions, and iron overload. Liver function tests (bilirubin, serum aminotransferases, and alkaline phosphatase) are routinely monitored every three to four months during the first year after HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The monitoring schedule after the first year varies, but most clinicians advocate for measurement of liver function tests at least annually. Liver involvement by chronic GVHD typically has a cholestatic presentation as demonstrated by an increased bilirubin and alkaline phosphatase. In the absence of other manifestations of chronic GVHD, a liver biopsy is used to confirm the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23962?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease\", section on 'Liver'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H622014623\">",
"    <span class=\"h3\">",
"     Hepatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a history of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are at risk for the reactivation of latent hepatitis and for the development of liver failure. Care should be administered in conjunction with a liver or infectious disease specialist, whenever possible. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/45/43735?source=see_link\">",
"     \"Overview of the management of chronic hepatitis C virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/50/31530?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical manifestations and natural history of chronic hepatitis C virus infection\", section on 'Liver biopsy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26009?source=see_link\">",
"     \"Hepatitis B virus reactivation associated with immunosuppression\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with a history of HBV infection, including those who had acute but not chronic HBV infection prior to transplantation, are at risk for reactivation following HCT. Patients are commonly monitored with liver function tests and either hepatitis B surface antigen (HbsAg) or a hepatitis B viral load, if indicated. The frequency of measurement is dependent on the degree of ongoing immunosuppression, but should be at least annually [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2\">",
"       1,2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with HCV are monitored with liver function tests and hepatitis C viral load at least annually [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. Approximately one-quarter of patients with long-term HCV infection will progress to cirrhosis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      malignancy. Treatment directed at the HCV decreases this risk. However, the management of HCV infection post-HCT can be complicated by the use of immunosuppressive therapy for chronic graft-versus-host disease (GVHD) and the potential of GVHD exacerbation by interferon. In addition, patients who have had chronic HCV infection for 8 to 10 years should be considered for a liver biopsy to assess for cirrhosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/6/28778?source=see_link&amp;anchor=H61645279#H61645279\">",
"       \"Prevention of hepatocellular carcinoma and recommendations for surveillance in adults with chronic liver disease\", section on 'Surveillance methods'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172320281\">",
"    <span class=\"h3\">",
"     Iron overload",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic transfusional support related to the primary disease and transplantation procedure may lead to iron overload and secondary hemochromatosis, with the potential for long term hepatic, pancreatic, gonadal, infectious, and cardiac complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Approximately one-third of long-term allogeneic HCT survivors will have evidence of iron overload [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/38\">",
"     38",
"    </a>",
"    ]. Plasma ferritin is commonly used to screen for iron overload in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In the absence of acute inflammation, plasma ferritin concentration above 300",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    in men and 200",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    in women suggests iron overload, which can be confirmed with a liver biopsy. Further ferritin level testing is not necessary for patients who have normal ferritin levels and no longer need blood product support. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/19/35129?source=see_link\">",
"     \"Pathophysiology and diagnosis of iron overload syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/60/38856?source=see_link\">",
"     \"Iron overload syndromes other than hereditary hemochromatosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/49/25370?source=see_link\">",
"     \"Chelation therapy for iron overload states\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492382\">",
"    <span class=\"h2\">",
"     Renal dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of renal disease (ie, a sustained decrease in glomerular filtration rate below 60",
"    <span class=\"nowrap\">",
"     mL/min/1.73",
"    </span>",
"    m",
"    <sup>",
"     2",
"    </sup>",
"    ) after HCT varies widely, with estimates as low as 4.4 percent up to 65 percent in long-term allograft survivors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/2,39,40\">",
"     2,39,40",
"    </a>",
"    ]. Risk factors include radiation injury, chronic calcineurin inhibitor use, hypertension and microangiopathy (both often a consequence of calcineurin inhibitor use). In addition, membranous glomerulopathy and other autoimmune-like diseases of the glomerulus have been associated with chronic GVHD in allogeneic transplant recipients. Patients with clinical or subclinical renal disease prior to HCT are at greater risk of developing more severe renal disease after HCT. The initial premise that total body irradiation-free reduced intensity preparative regimens would be associated with a reduced incidence of chronic renal injury does not appear to be true [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/36/1609?source=see_link\">",
"     \"Kidney disease following hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Renal function should be evaluated annually with serum creatinine, blood urea nitrogen, urinalysis, and urine microalbumin. Presenting signs of chronic renal injury include reductions in the glomerular filtration rate and proteinuria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492389\">",
"    <span class=\"h2\">",
"     Endocrine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term survivors of HCT commonly have alterations of their endocrine system, often related to the pre-HCT preparative (conditioning) regimen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the chronic administration of glucocorticoids for the treatment of chronic graft-versus-host disease. These include type 2 diabetes mellitus and the metabolic syndrome, hypothyroidism, osteopenia, hypogonadism, infertility, and hypoadrenalism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492397\">",
"    <span class=\"h3\">",
"     Diabetes/metabolic syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of type 2 diabetes mellitus is increased three- to fourfold after allogeneic HCT, but not after autologous HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/42\">",
"     42",
"    </a>",
"    ]. Risk factors include the use of glucocorticoids and calcineurin inhibitors for the management of graft-versus-host disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/42\">",
"     42",
"    </a>",
"    ]. A cohort analysis reported an incidence of diabetes of 30 percent at two years after allogeneic HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/22\">",
"     22",
"    </a>",
"    ]. The association of diabetes with hyperlipidemia and hypertension (&ldquo;metabolic syndrome&rdquo;) is common after transplantation since the individual components of this syndrome share several common risk factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/43\">",
"     43",
"    </a>",
"    ]. Untreated metabolic syndrome is associated with accelerated cardiovascular disease and must be recognized early for effective intervention. (See",
"    <a class=\"local\" href=\"#H94492366\">",
"     'Cardiovascular disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    All transplant survivors should be screened annually for diabetes using either fasting glucose or glycosylated hemoglobin (A1C) measurement and for hyperlipidemia using a fasting lipid assay.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492405\">",
"    <span class=\"h3\">",
"     Hypothyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypothyroidism is common after HCT; the incidence of clinical hypothyroidism is roughly double that of sibling controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/44\">",
"     44",
"    </a>",
"    ]. Clinical hypothyroidism is associated with chemotherapy-only conditioning regimens, but the incidence is much higher for regimens that include total-body irradiation, with single fraction irradiation being a greater risk than fractionated dose regimens.",
"   </p>",
"   <p>",
"    All HCT survivors should have an assay of thyroid stimulating hormone (TSH) measured at one year from HCT and at least annually thereafter. If the serum TSH concentration is elevated, the TSH measurement should be repeated along with a serum free T4 to make the diagnosis of hypothyroidism. Assays can be performed earlier if clinical suspicion exists, but the clinician must be aware of the possibility of acquired transient central hypothyroidism (the sick-euthyroid syndrome) early after transplantation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/7/26744?source=see_link\">",
"     \"Diagnosis of and screening for hypothyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44663?source=see_link\">",
"     \"Thyroid function in nonthyroidal illness\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492421\">",
"    <span class=\"h3\">",
"     Hypogonadism and fertility issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Temporary or permanent hypogonadism is common in men and women after both autologous and allogeneic transplantation. Hypogonadism is more common in women than men. Myeloablative allogeneic transplantation almost always causes permanent sterility, although rare exceptions have been noted. Changes in hormone levels can be accompanied by a loss of libido, erectile dysfunction, vaginal dryness, and dyspareunia. In addition, patients who have undergone allogeneic transplantation may have vulvovaginal graft-versus-host disease, often with mixed mucosal (vaginal) and cutaneous (vulvar) manifestations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1447?source=see_link\">",
"     \"Ovarian failure due to anticancer drugs and radiation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/24/13706?source=see_link\">",
"     \"Effects of cytotoxic agents on gonadal function in adult men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/50/7977?source=see_link\">",
"     \"Overview of fertility and pregnancy in cancer survivors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8039?source=see_link\">",
"     \"Clinical manifestations and diagnosis of vaginal atrophy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/50/6954?source=see_link\">",
"     \"Treatment of vaginal atrophy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/5/42073?source=see_link&amp;anchor=H733468#H733468\">",
"     \"Cutaneous manifestations of graft-versus-host disease (GVHD)\", section on 'Ocular and genital mucosa'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A case-control cohort study of 120 survivors of myeloablative HCT and 120 sibling or friend controls not treated with HCT evaluated fertility at 10 years post-HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/45\">",
"     45",
"    </a>",
"    ]. Four male HCT survivors and no female HCT survivors successfully conceived after HCT. When compared with controls, HCT survivors were more likely to have tried unsuccessfully to have children post-HCT (12 versus 7 percent) and more likely to investigate alternative family-building options because of infertility (22 versus 9 percent). Fifty-four percent of HCT survivors under age 40 expressed concerns regarding their infertility. HCT survivors without children before HCT were more likely to express infertility concerns after 10 years.",
"   </p>",
"   <p>",
"    Patients should be questioned about their sexual health and referred for sexual health counseling, if appropriate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/46\">",
"     46",
"    </a>",
"    ]. Screening for sex hormone levels with appropriate replacement therapy is recommended one year or earlier after HCT. Repeat evaluation is indicated for abnormal results or if new symptoms emerge.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Men",
"      </strong>",
"      &mdash; Men with symptoms worrisome for hypogonadism (lack of libido, erectile dysfunction) should have their serum testosterone concentration measured. A low value usually indicates hypogonadism. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12824?source=see_link\">",
"       \"Clinical features and diagnosis of male hypogonadism\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1545?source=see_link\">",
"       \"Testosterone treatment of male hypogonadism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Women",
"      </strong>",
"      &mdash; Women with secondary amenorrhea or oligomenorrhea should be evaluated with a pregnancy test and FSH. An elevated FSH is consistent with ovarian failure. Most experts agree that women with premature ovarian failure should be considered for estrogen therapy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/63/37880?source=see_link&amp;anchor=H7#H7\">",
"       \"Management of spontaneous primary ovarian insufficiency (premature ovarian failure)\", section on 'Duration of estrogen therapy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1447?source=see_link\">",
"       \"Ovarian failure due to anticancer drugs and radiation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28851361\">",
"    <span class=\"h3\">",
"     Hypoadrenalism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chronic administration of glucocorticoids for the treatment of chronic graft-versus-host disease can suppress the hypothalamic-pituitary-adrenal function and result in adrenal insufficiency.",
"    <strong>",
"    </strong>",
"    Patients who have had prolonged exposure to glucocorticoids should be tapered slowly. Adrenal crisis may occur in patients who are abruptly withdrawn from exogenous glucocorticoids or who are under acute stress. Adrenal crisis is a life-threatening emergency that requires immediate treatment (",
"    <a class=\"graphic graphic_table graphicRef67329 \" href=\"mobipreview.htm?8/56/9100\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/47/42745?source=see_link\">",
"     \"Treatment of adrenal insufficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1059055434\">",
"    <span class=\"h2\">",
"     Bone and joint health",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term survivors of HCT are at risk of osteopenia and avascular necrosis of the hip or other joints [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Patients with chronic graft-versus-host disease require screening for glucocorticoid-induced myopathy and sclerotic changes in the skin and fascia that can limit joint mobility. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23173?source=see_link\">",
"     \"Glucocorticoid-induced myopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23962?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease\", section on 'Clinical and histologic features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/5/42073?source=see_link&amp;anchor=H877766#H877766\">",
"     \"Cutaneous manifestations of graft-versus-host disease (GVHD)\", section on 'Sclerotic manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Accelerated bone loss occurs after both autologous and allogeneic HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Factors associated with increased loss of bone mineral density include the use of posttransplant glucocorticoids, conditioning intensity and hypogonadism. The routine use of calcium or calcitonin after transplantation has not been shown to prevent the loss of bone mineral density [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/49\">",
"     49",
"    </a>",
"    ]; however, the use of bisphosphonates can prevent some, but not all, of the bone mineral loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/47/27386?source=see_link&amp;anchor=H15#H15\">",
"     \"Major side effects of systemic glucocorticoids\", section on 'Musculoskeletal'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a phase III study, 99 adults undergoing allogeneic HCT were randomly assigned to receive calcium, vitamin D, and hormone therapy with or without six intravenous infusions of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/62/3048?source=see_link\">",
"     pamidronate",
"    </a>",
"    administered before HCT and at one, two, three, six, and nine months after HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/49\">",
"     49",
"    </a>",
"    ]. Patients who received pamidronate sustained less bone loss as measured by dual energy x-ray absorptiometry (DEXA) at 12 months post-HCT and had a trend towards fewer vertebral fractures (three versus five fractures). Other studies have demonstrated that vertebral, but not femoral, bone loss recovers at least partially after HCT even without specific treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. Given the uncertain clinical benefit of bisphosphonates in this population, we reserve the use of bisphosphonates for patients with demonstrated osteopenia or other indications for bisphosphonate use.",
"   </p>",
"   <p>",
"    All patients should be screened for osteopenia with DEXA one year after transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In addition, patients should be encouraged to take advantage of preventative measures commonly used in other patient populations including regular physical activity, supplemental calcium and vitamin D, and estrogen replacement for women with premature ovarian failure. (See",
"    <a class=\"local\" href=\"#H28851361\">",
"     'Hypoadrenalism'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/21/33113?source=see_link\">",
"     \"Prevention of osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Avascular necrosis of a major joint will occur in four to ten percent of long-term survivors of HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2,53\">",
"     1,2,53",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"    Risk factors include prolonged glucocorticoid use and exposure to total body irradiation. The most commonly involved joints are the hips (80 percent), knees (10 percent), wrists, and ankles. Most patients present with joint pain and standard radiographs may be normal. The diagnosis is usually confirmed on magnetic resonance imaging (MRI). Early consultation with an orthopedic specialist should be obtained. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/43/28346?source=see_link\">",
"     \"Osteonecrosis (avascular necrosis of bone)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H983951405\">",
"    <span class=\"h2\">",
"     Dermatologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;The skin is the most common organ involved in acute and chronic graft-versus-host disease (GVHD). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/5/42073?source=see_link\">",
"     \"Cutaneous manifestations of graft-versus-host disease (GVHD)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As with the oral mucosa, an excess of premalignant and malignant skin neoplasms occur after transplantation, an annual complete skin examination is required for monitoring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Examination of the skin and skin-derived structures (ie, nail beds, hair) should include a careful examination for the early signs of GVHD (follicular erythema, dyspigmentation, focal induration, joint contracture). Patients should be counselled to prevent sun burn and damage (dermatoheliosis) and to prevent severe dryness (xerosis), a risk factor for GVHD and cutaneous infections. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23962?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease\", section on 'Mucocutaneous manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/20/16713?source=see_link\">",
"     \"Skin examination and clinical features of melanoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/17/43287?source=see_link\">",
"     \"Benign pigmented skin lesions other than melanocytic nevi (moles)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492429\">",
"    <span class=\"h2\">",
"     Oral health",
"    </span>",
"    &nbsp;&mdash;&nbsp;Irradiation of the head and neck and chronic graft-versus-host disease (GVHD) are associated with the development of chronic dry mouth (xerostomia) and oral cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/54\">",
"     54",
"    </a>",
"    ]. Appropriate screening for the chronic oral complications of transplantation by an oral medicine specialist or dentist is recommended 6 to 12 months after transplantation, and at least twice a year thereafter (",
"    <a class=\"graphic graphic_table graphicRef87217 \" href=\"mobipreview.htm?30/2/30764\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Chronic xerostomia can be a complication of total body irradiation therapy, focal irradiation prior to transplant (for patients with lymphomas involving the head and neck) and chronic salivary gland GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/55\">",
"     55",
"    </a>",
"    ]. Chronic xerostomia significantly increases the risk of developing accelerated dental caries, particularly along the gum line and in between teeth. In addition, chronic xerostomia, mucosal chronic GVHD, and sclerodermatous GVHD involving the oral aperture are all associated with difficulty with mastication and swallowing, which can result in chronic malnutrition. The treatment of chronic xerostomia is symptomatic (eg, rinsing with saline or the use of commercially available saliva substitutes). Dry, cracked lips can be treated with petroleum lubricants. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/57/36762?source=see_link\">",
"     \"Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Long-term survivors of allogeneic HCT have a sevenfold increased risk of developing oral cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/56\">",
"     56",
"    </a>",
"    ]. Squamous cell oral cancers are particularly common among patients with Fanconi&rsquo;s anemia who have undergone HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/2\">",
"     2",
"    </a>",
"    ]. Common presenting features of intraoral malignancy include nonhealing ulcers, mucosal growths and induration. Early cancerous lesions may appear similar to chronic GVHD and are identifiable as malignancies only with tissue biopsy.",
"   </p>",
"   <p>",
"    Persons who underwent HCT in their childhood may have additional complications with their teeth including damaged enamel, permanent discoloration, and abnormal tooth development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492436\">",
"    <span class=\"h2\">",
"     Ocular complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common ocular complications of HCT include cataracts and chronic dry eye (keratoconjunctivitis sicca) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1\">",
"     1",
"    </a>",
"    ]. Other increasingly recognized complications of the anterior and posterior chambers of the eye include uveitis, choroiditis, infectious retinitis, and retinal microvascular disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Cataracts",
"      </strong>",
"      &mdash; Cataracts develop in almost all patients who receive total body irradiation (TBI) as part of their preparative regimen for HCT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/55\">",
"       55",
"      </a>",
"      ]. In addition, there appears to be an increased incidence of this complication after non-TBI based preparative regimens. Cataract development is a particularly common long-term complication of pediatric transplantation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/15\">",
"       15",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/19/2362?source=see_link\">",
"       \"Cataract in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Keratoconjunctivitis sicca",
"      </strong>",
"      &mdash; Chronic graft-verus-host disease (GVHD) and total body irradiation commonly decrease lacrimal gland function resulting in chronic dry eye (keratoconjunctivitis sicca) in the long-term HCT survivor. Tear production can be measured with the Schirmer test. The incidence of keratoconjunctivitis sicca is approximately 20 percent at 15 years post allogeneic HCT and may be as high as 40 percent among patients with chronic GVHD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/22/18794?source=see_link&amp;anchor=H11#H11\">",
"       \"Classification and diagnosis of Sj&ouml;gren's syndrome\", section on 'Tests for KCS'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Management revolves around the optimization of GVHD therapy and symptomatic control. In addition to topical therapy with lubricating drops, temporary or permanent punctal occlusion can be helpful. Most patients do not tolerate standard contact lenses and require special scleral lenses if contact lenses are desired. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/12/26826?source=see_link\">",
"       \"Treatment of dry eyes in Sj&ouml;gren's syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Ischemic microvascular retinopathy",
"      </strong>",
"      &mdash; Ischemic microvascular retinopathy may complicate allogeneic HCT and is characterized by cotton-wool spots and optic disc edema with or without a decrease in visual acuity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/2\">",
"       2",
"      </a>",
"      ]. This is most commonly seen in patients receiving",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      for GVHD prophylaxis. Changes often resolve following the withdrawal or reduction of immunosuppression.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An initial ophthalmologic evaluation should be performed at one year (or earlier if changes in visual acuity are noted) by an ophthalmologist knowledgeable in the potential complications of transplantation. This evaluation should include an assessment of visual acuity and tear production (using the Schirmer test).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492451\">",
"    <span class=\"h2\">",
"     Infectious disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection is a common cause of morbidity and non-relapse mortality following HCT. Prevention of infection is of paramount importance since antimicrobial therapy is typically less effective than in the unimpaired host. The majority of immune reconstitution takes place over the first 12 to 18 months post-HCT. Consequently, the risk of infection is highest in the first two years, but may be increased for several years in some patients. The risk of infectious complications following HCT varies depending upon the type of HCT, the time elapsed since HCT, and the presence of other transplant-related complications:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immune reconstitution is slower after allogeneic HCT and is especially prolonged for those with HLA-mismatched donors, T-cell depleted grafts, and chronic graft-versus-host-disease (GVHD).",
"     </li>",
"     <li>",
"      Immune reconstitution can be monitored indirectly by measuring immunoglobulin levels, the absolute CD4 count,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <span class=\"nowrap\">",
"       CD4/CD8",
"      </span>",
"      ratios. At a minimum, we recommend measurement of immunoglobulin levels and a CD4 count one year after transplantation. Persistent low absolute CD4 counts",
"      <span class=\"nowrap\">",
"       (&lt;400/microL)",
"      </span>",
"      are an indication to continue immune prophylaxis. Patients with severe infections and persistent hypogammaglobulinemia should be considered for intravenous immunoglobulin. Continued immune prophylaxis with antiviral and antipneumocystis therapy beyond one year from transplantation should occur in the presence of chronic GVHD, in the presence of very low CD4 counts (ie,",
"      <span class=\"nowrap\">",
"       &lt;100/&mu;L)",
"      </span>",
"      or in those who remain on immunosuppression. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/11/28857?source=see_link\">",
"       \"General principles in the use of immune globulin\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/57/32666?source=see_link\">",
"       \"Prophylaxis of infections in hematopoietic cell transplant recipients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      HCT recipients typically lose immunity to pathogens against which they were previously immunized. Thus, HCT recipients require repeat immunization according to current guidelines issued by the Center for Disease Control or American Society of Blood and Marrow Transplantation (",
"      <a class=\"graphic graphic_table graphicRef59497 \" href=\"mobipreview.htm?19/58/20397\">",
"       table 4",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/57,58\">",
"       57,58",
"      </a>",
"      ]. Inactivated vaccines are safe, but are less immunogenic in HCT recipients compared with immunocompetent individuals. Most inactivated vaccine series should be initiated 6 to 12 months following transplantation. Vaccination status for those not yet vaccinated should be readdressed at each visit. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/57/25498?source=see_link\">",
"       \"Immunizations after hematopoietic cell transplantation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients who have undergone HCT are at risk for reactivation of latent viral infections and for the acquisition of viral infections transmitted through blood transfusion, although the latter is extremely rare. Measurement of hepatitis B and C viral load measurement at the one year mark after transplant is reasonable. Patients who were seropositive prior to transplantation are at risk of hepatitis reactivation while immunosuppressed. (See",
"      <a class=\"local\" href=\"#H622014623\">",
"       'Hepatitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are special considerations in functionally or anatomically asplenic patients. Patients who have functional asplenia following HCT or those with previous splenectomy are at risk for infections due to the absence of the spleen. These include infections caused by encapsulated bacteria (such as S. pneumoniae, H. influenzae, Neisseria spp, and Capnocytophaga canimorsus) and in certain geographic areas by intraerythrocytic parasites (such as Babesia microti). This is discussed in more detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/42/9895?source=see_link\">",
"       \"Clinical features and management of sepsis in the asplenic patient\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/9/1177?source=see_link\">",
"       \"Prevention of sepsis in the asplenic patient\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Management of infections after HCT is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/30/25066?source=see_link\">",
"     \"Overview of infections following hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H83240821\">",
"    <span class=\"h2\">",
"     Secondary malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing hematopoietic cell transplantation have an increased risk of secondary malignancy that most often occurs many years following the transplantation procedure. This subject is discussed in depth separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/39/28280?source=see_link\">",
"     \"Malignancy after hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Survivors of cancer and HCT do not have better patterns of preventive health behavior when compared with non-cancer patients despite having higher levels of engagement with health care providers and should be encouraged to participate in routine age-appropriate cancer surveillance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/4\">",
"     4",
"    </a>",
"    ]. The primary indication for HCT and the initial treatment of the underlying disease may also affect cancer screening recommendations. Twenty to 30 percent of female patients who received chest irradiation before the age of 35 will develop breast cancer (",
"    <a class=\"graphic graphic_table graphicRef78361 \" href=\"mobipreview.htm?22/5/22620\">",
"     table 5",
"    </a>",
"    ). Based on the high risk of breast cancer in woman who received radiation to the chest between the age of 10 and 35 years, annual breast magnetic resonance imaging (MRI) screening has been recommended as an adjunct to mammography by an expert panel convened by the American Cancer Society [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37962?source=see_link&amp;anchor=H9#H9\">",
"     \"Overview of preventive medicine in adults\", section on 'Cancer morbidity and mortality'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/0/3079?source=see_link&amp;anchor=H1167672651#H1167672651\">",
"     \"Long-term follow-up of the patient with classical Hodgkin lymphoma\", section on 'Routine testing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94492458\">",
"    <span class=\"h2\">",
"     Psychosocial and neurologic health",
"    </span>",
"    &nbsp;&mdash;&nbsp;Special care must be given to psychological health of the transplant survivor and that of their",
"    <span class=\"nowrap\">",
"     spouse/partner,",
"    </span>",
"    and involvement of mental health providers in the long-term care of the transplant survivor is essential [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. When compared with their siblings, long-term allogeneic transplant survivors are less likely to be married, more likely to have health-related issues preventing them from holding a job, and more likely to report difficulty maintaining health insurance and acquiring life insurance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/7,63,64\">",
"     7,63,64",
"    </a>",
"    ]. In addition, transplant patients may have deficits in cognition that can only be revealed on detailed neuropsychological testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/65,66\">",
"     65,66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for neurocognitive impairment post-HCT include allogeneic HCT, prolonged immunosuppression with calcineurin inhibitors, exposure to total body irradiation, cranial irradiation, and a history of intrathecal chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2,67\">",
"     1,2,67",
"    </a>",
"    ]. All patients at increased risk should undergo screening for neurocognitive impairment so that appropriate occupational therapy and social services referrals may be made, if necessary. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/22/37226?source=see_link\">",
"     \"Complications of cranial irradiation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is known that graft-versus-host disease (GVHD) has a major impact on the quality of life of transplant survivors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/68\">",
"     68",
"    </a>",
"    ], but even in the absence of GVHD, significant psychological distress can occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/61\">",
"     61",
"    </a>",
"    ]. While often dismissed as being less important than physical complications of transplantation, depression after transplantation has been associated with inferior outcome. Patients should undergo screening and appropriate counseling should depressive symptoms occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/69\">",
"     69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/59/25529?source=see_link\">",
"     \"Quality of life following hematopoietic cell transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/13/11481?source=see_link&amp;anchor=H22#H22\">",
"     \"Clinical manifestations and diagnosis of depression\", section on 'Screening for depression'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other factors that may impair the transition back to normalcy after transplantation include issues with exercise tolerance, disturbances in taste, obesity, and sexual health. Exercise physiologists, nutritionists, and sexual health counsellors may be appropriate in select patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27546050\">",
"    <span class=\"h1\">",
"     COORDINATION OF CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ideally, specialized transplantation survivorship care should be provided to address the needs of the long-term hematopoietic cell transplantation (HCT) survivor. The model for HCT survivorship medicine involves clinicians in multiple fields of medicine and allied health sciences and is a paradigm for cooperation among medical subspecialists. While a multispecialty clinic that can cater to the individual needs of the long-term HCT patient is preferred, this multispecialty clinic model may not be practical in centers that do not perform many HCT procedures or for patients who live far away from their transplant center. As such, a significant percentage of HCT survivors return to their local",
"    <span class=\"nowrap\">",
"     hematologist/oncologist",
"    </span>",
"    or primary care physician for long-term care.",
"   </p>",
"   <p>",
"    Transplant survivors may have specific needs in multiple areas, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cardiology and vascular medicine",
"     </li>",
"     <li>",
"      Respiratory medicine",
"     </li>",
"     <li>",
"      Nephrology",
"     </li>",
"     <li>",
"      Endocrinology (including bone and",
"      <span class=\"nowrap\">",
"       sexual/reproductive",
"      </span>",
"      health)",
"     </li>",
"     <li>",
"      Oral medicine",
"     </li>",
"     <li>",
"      Ophthalmology",
"     </li>",
"     <li>",
"      Dermatology",
"     </li>",
"     <li>",
"      Infectious disease",
"     </li>",
"     <li>",
"      Nutrition",
"     </li>",
"     <li>",
"      Exercise physiology",
"     </li>",
"     <li>",
"      Cognitive and psychosocial health",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Guidelines have been established for appropriate screening studies to monitor for long-term complications of HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1,2\">",
"     1,2",
"    </a>",
"    ], but these guidelines and long-term problems associated with HCT may not be familiar to clinicians who are not transplantation specialists [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/70\">",
"     70",
"    </a>",
"    ]. This is particularly important because some transplant centers &ldquo;discharge&rdquo; patients several months after transplantation to the care of the referring",
"    <span class=\"nowrap\">",
"     hematologist/oncologist",
"    </span>",
"    or primary care physician. For centers in which patients have been discharged and the long-term care is done elsewhere, it is important to ensure that all long term complications of HCT are reported to both the transplant team and current medical provider. When patients are discharged from direct care in a transplant center, responsibilities for follow-up of the individual test results should be clearly delineated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/44/35530/abstract/71\">",
"     71",
"    </a>",
"    ]. A comprehensive plan for future screening and monitoring tests should be devised, and the plan should be clearly communicated to the primary treating team. As part of the plan, it is crucial to report long-term adverse events back to the transplant center to help shape future long-term follow-up plans and to aid in the planning strategies to prevent these adverse outcomes. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/47/2802?source=see_link\">",
"       \"Patient information: Bone marrow transplant (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/4/34886?source=see_link\">",
"       \"Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H83240493\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hematopoietic cell transplantation (HCT) is a general term for a variety of procedures in which the patient is treated with chemotherapy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      radiation therapy followed by the infusion of hematopoietic progenitor cells to reconstitute the bone marrow. HCT can be broadly divided into subtypes based upon the hematopoietic cell donor, the source of hematopoietic progenitor cells, and the preparative regimen. Each of these factors influences efficacy and the short and long-term toxicities associated with the procedure. (See",
"      <a class=\"local\" href=\"#H83240218\">",
"       'Terminology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HCT survivors are at risk of developing therapy-related complications that may present years after treatment. These complications have surfaced as significant causes of increased mortality, and screening for some of these entities is advised in the hope that early detection may lead to better management. Our approach to the ongoing evaluation of the long-term HCT survivor is in general agreement with published guidelines (",
"      <a class=\"graphic graphic_table graphicRef59471 \" href=\"mobipreview.htm?39/41/40604\">",
"       table 1",
"      </a>",
"      ). Performance and interpretation of the recommended tests often involve consultation with subspecialists. (See",
"      <a class=\"local\" href=\"#H622013943\">",
"       'Overview of care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A significant percentage of HCT survivors return to their local",
"      <span class=\"nowrap\">",
"       hematologist/oncologist",
"      </span>",
"      or primary care physician for long-term care. For centers in which patients have been discharged and the long-term care is done elsewhere, it is important to ensure that the abnormal results of screening tests are reported to both the transplant team and current medical provider. In addition, the responsibilities for follow-up of the individual test results should be clearly delineated. (See",
"      <a class=\"local\" href=\"#H27546050\">",
"       'Coordination of care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common long term complications of autologous HCT are decreased lung function, infection, cardiovascular disease, and secondary malignancies. (See",
"      <a class=\"local\" href=\"#H172320119\">",
"       'Autologous HCT survivor'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Long term complications of allogeneic HCT include chronic graft-versus-host disease (GVHD), infections, treatment-related",
"      <span class=\"nowrap\">",
"       myelodysplasia/secondary",
"      </span>",
"      leukemia, secondary solid tumors, cardiac disease, and pulmonary toxicity. (See",
"      <a class=\"local\" href=\"#H172320127\">",
"       'Allogeneic HCT survivor'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are unique aspects of transplant survivorship in pediatric patients that deserve attention at specialized transplant centers including physical and neuropsychological growth and development and the psychological effects of prolonged illness in children. (See",
"      <a class=\"local\" href=\"#H28851851\">",
"       'Pediatric transplant survivor'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/1\">",
"      Rizzo JD, Wingard JR, Tichelli A, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006; 12:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/2\">",
"      Majhail NS, Rizzo JD, Lee SJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012; 18:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/3\">",
"      Findley PA, Sambamoorthi U. Preventive health services and lifestyle practices in cancer survivors: a population health investigation. J Cancer Surviv 2009; 3:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/4\">",
"      Bishop MM, Lee SJ, Beaumont JL, et al. The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. Biol Blood Marrow Transplant 2010; 16:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/5\">",
"      Armenian SH, Sun CL, Francisco L, et al. Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor Study. Bone Marrow Transplant 2012; 47:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/6\">",
"      Sun CL, Francisco L, Kawashima T, et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood 2010; 116:3129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/7\">",
"      Bhatia S, Francisco L, Carter A, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110:3784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/8\">",
"      Nivison-Smith I, Simpson JM, Dodds AJ, et al. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates. Biol Blood Marrow Transplant 2009; 15:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/9\">",
"      Martin PJ, Counts GW Jr, Appelbaum FR, et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 2010; 28:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/10\">",
"      Wingard JR, Majhail NS, Brazauskas R, et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 2011; 29:2230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/11\">",
"      Hill BT, Rybicki L, Bolwell BJ, et al. The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls. Br J Haematol 2011; 152:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/12\">",
"      Khera N, Storer B, Flowers ME, et al. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J Clin Oncol 2012; 30:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/13\">",
"      Hoffmeister PA, Madtes DK, Storer BE, Sanders JE. Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation. Pediatr Blood Cancer 2006; 47:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/14\">",
"      Hoffmeister PA, Hingorani SR, Storer BE, et al. Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010; 16:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/15\">",
"      Gurney JG, Ness KK, Rosenthal J, et al. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study. Cancer 2006; 106:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/16\">",
"      Hoffmeister PA, Storer BE, Sanders JE. Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. J Pediatr Hematol Oncol 2004; 26:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/17\">",
"      Sanders JE, Woolfrey AE, Carpenter PA, et al. Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. Blood 2011; 118:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/18\">",
"      Armenian SH, Sun CL, Kawashima T, et al. Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood 2011; 118:1413.",
"     </a>",
"    </li>",
"    <li>",
"     Long-term follow-up guidelines from the Children's Oncology Group www.survivorshipguidelines.org/pdf/LTFUGuidelines.pdf (Accessed on May 10, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/20\">",
"      Freycon F, Trombert-Paviot B, Casagranda L, et al. Final height and body mass index after fractionated total body irradiation and allogeneic stem cell transplantation in childhood leukemia. Pediatr Hematol Oncol 2012; 29:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/21\">",
"      Inaba H, Yang J, Kaste SC, et al. Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol 2012; 30:3991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/22\">",
"      Majhail NS, Challa TR, Mulrooney DA, et al. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2009; 15:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/23\">",
"      Tichelli A, Passweg J, W&oacute;jcik D, et al. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica 2008; 93:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/24\">",
"      Armenian SH, Sun CL, Shannon T, et al. Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation. Blood 2011; 118:6023.",
"     </a>",
"    </li>",
"    <li>",
"     Chow EJ, Baker KS, Friedman DL, et al. Population-Based Analysis of Late Cardiovascular Morbidity and Hospitalizations After Hematopoietic Cell Transplantation. ASH Annual Meeting Abstracts 2009; 114:517.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/26\">",
"      Chow EJ, Mueller BA, Baker KS, et al. Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Ann Intern Med 2011; 155:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/27\">",
"      Griffith ML, Savani BN, Boord JB. Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management. Blood 2010; 116:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/28\">",
"      Armenian SH, Sun CL, Mills G, et al. Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010; 16:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/29\">",
"      Armenian SH, Sun CL, Vase T, et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood 2012; 120:4505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/30\">",
"      Armenian SH, Sun CL, Francisco L, et al. Late congestive heart failure after hematopoietic cell transplantation. J Clin Oncol 2008; 26:5537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/31\">",
"      Steinherz LJ, Graham T, Hurwitz R, et al. Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics 1992; 89:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/32\">",
"      Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004; 22:4979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/33\">",
"      Shankar SM, Marina N, Hudson MM, et al. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics 2008; 121:e387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/34\">",
"      Parimon T, Madtes DK, Au DH, et al. Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med 2005; 172:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/35\">",
"      Walter EC, Orozco-Levi M, Ramirez-Sarmiento A, et al. Lung function and long-term complications after allogeneic hematopoietic cell transplant. Biol Blood Marrow Transplant 2010; 16:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/36\">",
"      Pullarkat V. Iron overload in patients undergoing hematopoietic stem cell transplantation. Adv Hematol 2010; 2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/37\">",
"      Majhail NS, Lazarus HM, Burns LJ. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant 2010; 16:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/38\">",
"      Majhail NS, DeFor T, Lazarus HM, Burns LJ. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors. Biol Blood Marrow Transplant 2008; 14:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/39\">",
"      Choi M, Sun CL, Kurian S, et al. Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation. Cancer 2008; 113:1580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/40\">",
"      Ando M, Ohashi K, Akiyama H, et al. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Nephrol Dial Transplant 2010; 25:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/41\">",
"      Al-Hazzouri A, Cao Q, Burns LJ, et al. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008; 14:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/42\">",
"      Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 2007; 109:1765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/43\">",
"      Majhail NS, Flowers ME, Ness KK, et al. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2009; 43:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/44\">",
"      Baker KS, Gurney JG, Ness KK, et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 2004; 104:1898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/45\">",
"      Hammond C, Abrams JR, Syrjala KL. Fertility and risk factors for elevated infertility concern in 10-year hematopoietic cell transplant survivors and case-matched controls. J Clin Oncol 2007; 25:3511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/46\">",
"      Thygesen KH, Schj&oslash;dt I, Jarden M. The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature. Bone Marrow Transplant 2012; 47:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/47\">",
"      Yao S, Smiley SL, West K, et al. Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010; 16:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/48\">",
"      Le Meignen M, Auquier P, Barlogis V, et al. Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities. Blood 2011; 118:1481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/49\">",
"      V&auml;lim&auml;ki MJ, Kinnunen K, Volin L, et al. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant 1999; 23:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/50\">",
"      Kananen K, Volin L, Laitinen K, et al. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab 2005; 90:3877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/51\">",
"      Kananen K, Volin L, T&auml;htel&auml; R, et al. Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 29:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/52\">",
"      Schulte CM, Beelen DW. Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood 2004; 103:3635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/53\">",
"      Campbell S, Sun CL, Kurian S, et al. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 2009; 115:4127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/54\">",
"      Treister N, Duncan C, Cutler C, Lehmann L. How we treat oral chronic graft-versus-host disease. Blood 2012; 120:3407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/55\">",
"      Majhail NS, Ness KK, Burns LJ, et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant 2007; 13:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/56\">",
"      Rizzo JD, Curtis RE, Soci&eacute; G, et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009; 113:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/57\">",
"      Centers for Disease Control and Prevention, Infectious Disease Society of America, American Society of Blood and Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000; 49:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/58\">",
"      Ljungman P, Cordonnier C, Einsele H, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009; 44:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/59\">",
"      Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/60\">",
"      Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/61\">",
"      Rusiewicz A, DuHamel KN, Burkhalter J, et al. Psychological distress in long-term survivors of hematopoietic stem cell transplantation. Psychooncology 2008; 17:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/62\">",
"      Bishop MM, Beaumont JL, Hahn EA, et al. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol 2007; 25:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/63\">",
"      Wong FL, Francisco L, Togawa K, et al. Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns. Blood 2010; 115:2508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/64\">",
"      Sun CL, Francisco L, Baker KS, et al. Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood 2011; 118:4723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/65\">",
"      Perkins JL, Kunin-Batson AS, Youngren NM, et al. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer 2007; 49:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/66\">",
"      Syrjala KL, Dikmen S, Langer SL, et al. Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood 2004; 104:3386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/67\">",
"      Jim HS, Small B, Hartman S, et al. Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation. Cancer 2012; 118:3407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/68\">",
"      Andrykowski MA, Bishop MM, Hahn EA, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 2005; 23:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/69\">",
"      Loberiza FR Jr, Rizzo JD, Bredeson CN, et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 2002; 20:2118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/70\">",
"      Shankar SM, Carter A, Sun CL, et al. Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study. Cancer Epidemiol Biomarkers Prev 2007; 16:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/44/35530/abstract/71\">",
"      Grunfeld E, Earle CC. The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr 2010; 2010:25.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14228 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-A7B94B43F3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35530=[""].join("\n");
var outline_f34_44_35530=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H83240493\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H94492335\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H83240218\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H622013943\">",
"      OVERVIEW OF CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H622014148\">",
"      Individualized care plan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H172320119\">",
"      - Autologous HCT survivor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H172320127\">",
"      - Allogeneic HCT survivor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28851851\">",
"      - Pediatric transplant survivor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H94492358\">",
"      COMMON MEDICAL PROBLEMS FOLLOWING TRANSPLANT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H94492366\">",
"      Cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H94492374\">",
"      Respiratory disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H622014608\">",
"      Liver disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H622014623\">",
"      - Hepatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H172320281\">",
"      - Iron overload",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H94492382\">",
"      Renal dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H94492389\">",
"      Endocrine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H94492397\">",
"      - Diabetes/metabolic syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H94492405\">",
"      - Hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H94492421\">",
"      - Hypogonadism and fertility issues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28851361\">",
"      - Hypoadrenalism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1059055434\">",
"      Bone and joint health",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H983951405\">",
"      Dermatologic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H94492429\">",
"      Oral health",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H94492436\">",
"      Ocular complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H94492451\">",
"      Infectious disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H83240821\">",
"      Secondary malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H94492458\">",
"      Psychosocial and neurologic health",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27546050\">",
"      COORDINATION OF CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H83240493\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/14228\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/14228|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?10/27/10687\" title=\"algorithm 1\">",
"      Doxorubicin monitoring children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/14228|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/41/40604\" title=\"table 1\">",
"      Annual testing for hematopoietic cell transplantation survivors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/56/9100\" title=\"table 2\">",
"      Treatment of adrenal crisis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/2/30764\" title=\"table 3\">",
"      Guidelines cGVHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/58/20397\" title=\"table 4\">",
"      Vaccines for HCT recipients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/5/22620\" title=\"table 5\">",
"      Breast cancer risk Hodgkin lymphoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/17/43287?source=related_link\">",
"      Benign pigmented skin lesions other than melanocytic nevi (moles)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/46/41706?source=related_link\">",
"      Cardiotoxicity of anthracycline-like chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/12/40138?source=related_link\">",
"      Cardiotoxicity of nonanthracycline cancer chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/21/34137?source=related_link\">",
"      Cardiotoxicity of radiation therapy for malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/19/2362?source=related_link\">",
"      Cataract in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/49/25370?source=related_link\">",
"      Chelation therapy for iron overload states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/22/18794?source=related_link\">",
"      Classification and diagnosis of Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12824?source=related_link\">",
"      Clinical features and diagnosis of male hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/42/9895?source=related_link\">",
"      Clinical features and management of sepsis in the asplenic patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8039?source=related_link\">",
"      Clinical manifestations and diagnosis of vaginal atrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/50/31530?source=related_link\">",
"      Clinical manifestations and natural history of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23962?source=related_link\">",
"      Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/22/37226?source=related_link\">",
"      Complications of cranial irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/5/42073?source=related_link\">",
"      Cutaneous manifestations of graft-versus-host disease (GVHD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=related_link\">",
"      Cyclosporine and tacrolimus nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/7/26744?source=related_link\">",
"      Diagnosis of and screening for hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/38/26218?source=related_link\">",
"      Donor selection for hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/24/13706?source=related_link\">",
"      Effects of cytotoxic agents on gonadal function in adult men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/7/7286?source=related_link\">",
"      Endocrine surveillance in childhood cancer survivors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/11/28857?source=related_link\">",
"      General principles in the use of immune globulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23173?source=related_link\">",
"      Glucocorticoid-induced myopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/54/34664?source=related_link\">",
"      Hematopoietic support after hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26009?source=related_link\">",
"      Hepatitis B virus reactivation associated with immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/57/25498?source=related_link\">",
"      Immunizations after hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/60/38856?source=related_link\">",
"      Iron overload syndromes other than hereditary hemochromatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/36/1609?source=related_link\">",
"      Kidney disease following hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/0/3079?source=related_link\">",
"      Long-term follow-up of the patient with classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/39/28280?source=related_link\">",
"      Malignancy after hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/63/37880?source=related_link\">",
"      Management of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/43/28346?source=related_link\">",
"      Osteonecrosis (avascular necrosis of bone)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1447?source=related_link\">",
"      Ovarian failure due to anticancer drugs and radiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/50/7977?source=related_link\">",
"      Overview of fertility and pregnancy in cancer survivors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/30/25066?source=related_link\">",
"      Overview of infections following hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37962?source=related_link\">",
"      Overview of preventive medicine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/45/43735?source=related_link\">",
"      Overview of the management of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/19/35129?source=related_link\">",
"      Pathophysiology and diagnosis of iron overload syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/47/2802?source=related_link\">",
"      Patient information: Bone marrow transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/4/34886?source=related_link\">",
"      Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/34/25130?source=related_link\">",
"      Preparative regimens for hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10425?source=related_link\">",
"      Prevention and treatment of acute graft-versus-host disease: Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/6/28778?source=related_link\">",
"      Prevention of hepatocellular carcinoma and recommendations for surveillance in adults with chronic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/21/33113?source=related_link\">",
"      Prevention of osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/9/1177?source=related_link\">",
"      Prevention of sepsis in the asplenic patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/57/32666?source=related_link\">",
"      Prophylaxis of infections in hematopoietic cell transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/14/7401?source=related_link\">",
"      Pubertal development and gonadal function in survivors of childhood cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/10/40106?source=related_link\">",
"      Pulmonary complications after allogeneic hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/25/14745?source=related_link\">",
"      Pulmonary complications after autologous hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/41/17050?source=related_link\">",
"      Pulmonary toxicity associated with antineoplastic therapy: Cytotoxic agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/49/29466?source=related_link\">",
"      Pulmonary toxicity associated with antineoplastic therapy: Molecularly targeted agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/59/25529?source=related_link\">",
"      Quality of life following hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/33/24090?source=related_link\">",
"      Radiation-induced lung injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/20/16713?source=related_link\">",
"      Skin examination and clinical features of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/49/38682?source=related_link\">",
"      Sources of hematopoietic stem cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29306?source=related_link\">",
"      Supportive care after hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1545?source=related_link\">",
"      Testosterone treatment of male hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44663?source=related_link\">",
"      Thyroid function in nonthyroidal illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/47/42745?source=related_link\">",
"      Treatment of adrenal insufficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/35/35385?source=related_link\">",
"      Treatment of chronic graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/12/26826?source=related_link\">",
"      Treatment of dry eyes in Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/57/36762?source=related_link\">",
"      Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/50/6954?source=related_link\">",
"      Treatment of vaginal atrophy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_44_35531="Eosinophilia drug reactions";
var content_f34_44_35531=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F62569&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F62569&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Eosinophilia and drug reactions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug reactions",
"       </td>",
"       <td class=\"subtitle1\">",
"        Examples",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cytokine-mediated",
"       </td>",
"       <td>",
"        GM-CSF, IL-2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary infiltrates",
"       </td>",
"       <td>",
"        Nonsteroidal antiinflammatory agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pleuropulmonary",
"       </td>",
"       <td>",
"        Dantrolene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interstitial nephritis",
"       </td>",
"       <td>",
"        Semisynthetic penicillins, cephalosporins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Necrotizing myocarditis",
"       </td>",
"       <td>",
"        Ranitidine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatitis",
"       </td>",
"       <td>",
"        Semisynthetic penicillins, tetracyclines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypersensitivity vasculitis",
"       </td>",
"       <td>",
"        Allopurinol, phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastroenterocolitis",
"       </td>",
"       <td>",
"        Nonsteroidal anti-inflammatory agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asthma, nasal polyps",
"       </td>",
"       <td>",
"        Aspirin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pharmacologic",
"       </td>",
"       <td>",
"        Beta blockers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophilia-myalgia syndrome",
"       </td>",
"       <td>",
"        L-tryptophan contaminant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asymptomatic",
"       </td>",
"       <td>",
"        Ampicillin, penicillins, cephalosporins",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35531=[""].join("\n");
var outline_f34_44_35531=null;
var title_f34_44_35532="ESC driving after ICD";
var content_f34_44_35532=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    European Society of Cardiology guidelines for driving restriction following implantation of an implantable cardioverter-defibrillator",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type of arrhythmia",
"       </td>",
"       <td class=\"subtitle1\">",
"        Noncommercial driving",
"       </td>",
"       <td class=\"subtitle1\">",
"        Commercial driving",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Class",
"I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Prophylactic ICD (primary prevention)",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        No restriction",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        Total restriction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Strong family",
"history of SCD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Nonsustained VT with LV dysfunction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Patients enrolled in",
"ICD research protocols",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        If appropriate shock during follow-up, particularly if",
"with disabling symptoms",
"       </td>",
"       <td>",
"        Six months",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Class II",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        All patients with ICD except for",
"prophylaxis&nbsp;&nbsp;",
"       </td>",
"       <td>",
"        Six months",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Total restriction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        If no ICD therapy for six months (class IIA)",
"       </td>",
"       <td class=\"sublist_other\">",
"        No restriction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        If ICD therapy at any time, with or without syncope or",
"presyncope (class IIB)",
"       </td>",
"       <td class=\"sublist_other\">",
"        Six months*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Class III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        High risk patients in class IIB with NYHA class III or",
"IV, LVEF &lt;40 percent, VT rate &ge;180 beats/min, and/or",
"three or more arrhythmia episodes per six months",
"       </td>",
"       <td>",
"        Total restriction until satisfactory control of",
"arrhythmia is achieved&bull;",
"       </td>",
"       <td>",
"        Total restriction",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Subsequent decision based upon the nature, frequency, and severity of arrhythmia recurrences. The level of consciousness from arrhythmia onset until ICD termination should be considered when deciding the fitness to drive. The patient may be allowed to drive after six months if recurrences are well tolerated and do not alter the level of consciousness. The patient should be advised not to drive if there are any disabling symptoms during arrhythmia recurrence.",
"     <br>",
"      &bull;&nbsp;In very selected patients, an exception can be made in patients who do not have impaired consciousness during arrhythmia episodes (eg, asymptomatic and well tolerated VT that is reliably and reproducibly terminated by antitachycardia pacing without arrhythmia acceleration).",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Jung, W, Anderson, M, Camm, AJ, et al. Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology. Eur Heart J 1997; 18:1210.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35532=[""].join("\n");
var outline_f34_44_35532=null;
var title_f34_44_35533="Brachial artery anatomy";
var content_f34_44_35533=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57543&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57543&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Brachial artery anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 301px; height: 207px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the relationship of the brachial artery to the antecubital crease and the median nerve. The artery should be entered just above the antecubital crease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35533=[""].join("\n");
var outline_f34_44_35533=null;
var title_f34_44_35534="Pandemic influenza mortality 1918";
var content_f34_44_35534=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 592px\">",
"   <div class=\"ttl\">",
"    Combined influenza and pneumonia mortality, United States, 1911-1918",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 572px; height: 413px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    \"U-\" and \"W-\" shaped combined influenza and pneumonia mortality, by age at death, per 100,000 persons in each age group, United States, 1911-1918. Influenza- and pneumonia-specific death rates are plotted for the interpandemic years 1911-1917 (orange line) and for the pandemic year 1918 (green line).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Taubenberger JK, Morens DM. 1918 influenza: The mother of all pandemics. Emerg Infect Dis 2006; 12:15.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35534=[""].join("\n");
var outline_f34_44_35534=null;
var title_f34_44_35535="Disease-specific survival MF SS";
var content_f34_44_35535=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F83542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F83542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Disease-specific survival for mycosis fungoides/S&eacute;zary syndrome by stage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 414px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Disease-specific survival according to (A) clinical stage and (B) T classification (International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/S&eacute;zary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 2010; 28:4730. Reprinted with permission. Copyright &copy; 2010 American Society of Oncology. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_44_35535=[""].join("\n");
var outline_f34_44_35535=null;
